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Abstract
Corticosteroid-binding globulin (CBG) transports glucocorticoids and
progesterone, but little is known about CBG in the bovine reproductive tract.
Pseudomonas aeruginosa is an environmental bacteria capable of colonizing the
vaginal cavity of other species. P. aeruginosa presence within the bovine vaginal cavity
is not well characterized, yet evidence suggests that a controlled internal drug release
device (CIDR) can alter the bacterial abundance within the cavity. P. aeruginosa
produces a protease that cleaves the reactive center loop of CBG allowing for the
release of the steroid into its active form. Thus, the objective of this study was to
examine effects of progesterone released from a CIDR on circulating and vaginal
concentrations of CBG, the proportion of free progesterone and cortisol, and presence
of P. aeruginosa following synchronization of ovulation. Prior to CIDR insertion (d -7)
and following removal (d 0), blood and vaginal flush samples were collected from each
heifer (n=67). Plasma collected at pregnancy diagnosis (d 38) from pregnant heifers
(n=24) had greater (P=0.02) concentrations of progesterone than samples collected on
d -7, but were similar to those measured on d 0. Similarly, plasma CBG concentrations
measured on d -7 and 0 did not differ, but were greatest (P=0.03) on d 38. The free
progesterone index (FPI) calculated from progesterone and CBG concentrations
measured on the three sampling days were not different (P=0.16). During the CIDR
insertion period, P. aeruginosa abundance decreased (P<0.0001), and on d 0, P.
aeruginosa abundance was related to both CBG concentration (r=-0.25; P=0.05) and
FCI (r=0.37; P=0.004). The third study aimed to determine if CBG mRNA is expressed
vi

within the vagina and uterus of abattoir-sourced reproductive tracts (n=3) to determine
the source of CBG within the vaginal cavity. In the tissues collected, CBG gene was not
expressed within the vaginal epithelium, but was expressed in the uterine endometrium.
In summary, CIDR insertion did not affect CBG concentrations, but CBG may regulate
the free fraction of progesterone in circulation during early gestation. Additionally, P.
aeruginosa within the vaginal cavity of heifers may alter the free proportion of cortisol as
seen by a reduction in CBG concentration.
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Introduction
Infertility poses a major economic detriment to the United States cattle industry.
It has been estimated that reproductive inefficiency constitutes a combined loss of
approximately $900 million per year within the dairy and beef cattle industries (Bellows
et al., 2002). With the world’s population expected to grow in excess of 9 billion people
by the year 2050 (Godfray et al., 2010), research efforts focused on improving the
reproductive efficiency of cattle remains of interest in order to continue the supply of
animal-derived protein to our growing population. To bolster reproductive efficiency, the
use of estrous synchronization protocols has gained popularity within both cattle
industries and relies on the use of coordinated administration of exogenous hormones.
Through this management technique, producers can easily identify cows and heifers
that fail to conceive during the breeding season and can make informed culling and
retention decisions.
The use of a controlled internal drug release device (CIDR) impregnated with
progesterone is common among protocols used to synchronize estrus in cows and
heifers to allow for coordinated ovulation and to facilitate subsequent artificial
insemination. However, a gap in knowledge exists in regards to the effect of exogenous
progesterone release from a CIDR on the local endocrine and bacterial profiles within
the bovine vaginal cavity. Recently, research has examined the interactions between
hormone production and bacterial community profiles that exist within the bovine
vagina, and it has been reported that changes in the diversity and abundance of
bacteria occur as hormone profiles vary (Laguardia-Nascimento et al., 2015).
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Furthermore, during pregnancy, a physiological state characterized by heightened
progesterone production, the bovine vaginal microbiome undergoes a reduction in both
bacterial diversity and the number of bacteria inhabiting the cavity (Walther-António et
al., 2014; Laguardia-Nascimento et al., 2015). Although research has aimed to
characterize the existing bacterial community profiles in the bovine vaginal cavity, the
direct effect of exogenous progesterone release from a CIDR on the local bacterial
community profile remains nebulous.
In regards to women, Pseudomonas aeruginosa is a bacterial pathogen that can
colonize the vaginal epithelium (Osset et al., 2001). Additionally, studies characterizing
the bovine vaginal bacterial community profiles reported that Pseudomonadaceae, the
family in which Pseudomonas aeruginosa belong, is present within the vaginal cavity
(Laguardia-Nascimento et al., 2015), and its abundance is augmented by progesterone
(Padula and Macmillan, 2006). Notably, this particular bacterial species has been
shown to release LasB, a protease that has the ability to cleave the reactive center loop
(RCL) of the steroid transporter, corticosteroid-binding globulin (CBG), a member of the
serine protease inhibitor super family (Simard et al., 2014; Hammond, 2016). After
cleavage of the RCL, steroid hormones such as progesterone and cortisol dissociate
from CBG and are then considered free or biologically available, and can serve their
physiological functions (Siiteri et al., 1981). Furthermore, it has been reported that
under conditions of elevated progesterone production, cortisol is displaced from CBG,
and in turn, CBG will primarily bind progesterone (Rosenthal et al., 1969; Hammond,
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2016). Therefore, the presence of proteases and local hormone production may both
play roles in determining the bioavailability of these steroid hormones.
Thus far, the presence of CBG within the uterine horns of swine and its
interaction with cortisol and progesterone concentration has been examined in our lab
(Klemcke et al., 1998), but to the best of our knowledge, CBG presence and possible
involvement in steroid hormone availability and associated bacterial interaction within
the bovine vaginal cavity has not been examined. In the study conducted by Klemcke
et al. (1998), it was postulated that CBG presence in the uterine horns of gilts served to
shuttle cortisol and progesterone within cavity, but the exact mechanism and source of
CBG was not known. It is possible that CBG acts to impede steroid catabolism to
ensure a constant steroid reserve (Benassayag et al., 2001). Furthermore, the
expression of CBG messenger ribonucleic acid (mRNA) has been reported within
various regions of the female reproductive tract in other species (Seralini et al., 1990;
Misao et al., 1994), but has not been characterized in cattle. To gain a better
understanding of the direct impact of CIDRs used to facilitate coordinated breeding, the
main goal of the research included in this dissertation is to investigate the vaginal
steroid hormone profile and associated bacterial interactions in beef heifers undergoing
synchronization of ovulation. Whereas, the second project in this dissertation aimed to
characterize CBG synthesis sites in the female bovine reproductive tract and examine
changes in CBG mRNA expression during different stages of the estrous cycle and
gestation. Through the completion of these experiments, the expected outcome was to
gain a better understanding of bovine CBG and its influence on the reproductive axis,
3

but to also gain insight as to the local production of CBG within the bovine reproductive
tract. Furthermore, investigating the impact of CBG on the bound and biologically
available fractions of progesterone within the reproductive tract during synchronization
may prove beneficial for further understanding the ability of heifers and cows to become
pregnant following estrous synchronization and artificial insemination.

4

Chapter I
Literature Review

5

Controlled internal drug release device (CIDR)
Estrous synchronization relies on coordinated administration of exogenous
reproductive hormones and many of the protocols developed and approved for use in
the United States rely on the use of a controlled internal drug release device (CIDR;
Eazi-Breed CIDR, Zoetis, Madison, NJ). In contrast to other exogenous hormones that
are administered by injection, CIDRs used to synchronize estrus in cattle are plastic
devices that are infused with progesterone (1.38 g; Eazi-Breed CIDR, Zoetis, Madison,
NJ, or 1.9 g; Eazi-Breed CIDR, São Paulo, Brazil) and after intravaginal insertion,
progesterone is absorbed through the vaginal epithelium and migrates to the vascular
system. Within an hour post-insertion, circulating concentrations of progesterone reach
a maximum peak and are sustained throughout a 7 d insertion period (Kesler, 2002).
Similar to the rapid rise in systemic progesterone concentration after insertion, systemic
progesterone rapidly decreases after the CIDR is removed and returns to baseline 8 hr
post-removal (Kesler, 2002).
Progesterone released by the CIDR has the capability to promote synchrony
among heifers and cows through two mechanisms. During a normal estrous cycle,
regression of the corpus luteum (CL) must occur to allow for the onset of estrus.
However, at the onset of the estrous synchronization process, cows and heifers may be
at various stages of the estrous cycle that may prevent successful luteal regression
(Kesler, 2002). Immature CL lack the ability to respond to prostaglandin F2α (PGF 2α)
and luteal regression does not occur until the CL acquires luteolytic capacity at
approximately d 6 of the estrous cycle (Tsai and Wiltbank, 1998; Diaz et al., 2000).
6

Insertion of CIDRs for a period of 7 d prior to PGF2α administration ensures the CL has
reached maturity and can undergo luteolysis following PGF 2α administration (Lucy et al.,
2001; Kesler, 2002).
Another way in which CIDRs are used to synchronize a herd of cattle is by
inducing cyclicity in pre-pubertal heifers and anestrous cows (Rhodes, 1998; Lucy et al.,
2001; Kesler, 2002). Specifically, Lucy et al. (2001) performed a study to evaluate
synchronization rates among pre-pubertal heifers and postpartum cows and reported
that heifers and cows administered a CIDR followed by an injection of PGF 2α displayed
estrus earlier in a 31-d breeding season. Additionally, greater pregnancy rates were
observed in heifers and cows that received a CIDR followed by PGF 2α when compared
to control animals with no hormone therapy and animals that received only an injection
of PGF2α. During the CIDR insertion period, the low dose release of progesterone
prevents follicular wave turn-over and promotes the development of a persistent
dominant follicle by increasing luteinizing hormone (LH) pulse frequency (Savio et al.,
1993; Kojima et al., 2003). As the persistent follicle continues to develop, estradiol
production and release subsequently increases (Kojima et al., 2003). Through positive
feedback on the hypothalamus, estradiol promotes the release of GnRH and
subsequent LH production and release from the anterior pituitary (Kesner et al., 1981),
and in pre-pubertal heifers and anestrous cows and this mechanism allows for the
resumption of cyclicity (Anderson et al., 1996; Imwalle et al., 1998). Additionally, the
removal of the CIDR and subsequent administration of PGF 2α and GnRH, ovulation of
the dominant follicle can occur to achieve synchrony and allow for coordinated
7

insemination. Although the physiological mechanisms behind the use of a CIDR are
well characterized, a gap in knowledge exists in regards to the effect of exogenous
progesterone release from a CIDR on the local bacterial and endocrine profiles within
the bovine vaginal cavity.
Interaction between progesterone and bacterial community profiles
Within the last few years, researchers have started to examine the interactions
between hormone production and bacterial community profiles that exist within the
bovine vagina, and it has been reported that changes in the diversity and abundance of
bacteria occur as hormone profiles vary (Laguardia-Nascimento et al., 2015).
Furthermore, during pregnancy, a physiological state characterized by heightened
progesterone production, the bovine vaginal microbiome undergoes a reduction in both
bacterial diversity and abundance of bacteria inhabiting the cavity (Walther-António et
al., 2014; Laguardia-Nascimento et al., 2015). Although research has aimed to
characterize the existing bacterial community profiles in the bovine vaginal cavity, the
direct effect of exogenous progesterone release from a CIDR on the local bacterial
community remains nebulous.
Presence of Pseudomonas aeruginosa in the vaginal cavity
In regards to women, Pseudomonas aeruginosa is an aerobic opportunistic
bacterial pathogen that has the capability to colonize the vaginal epithelium (Osset et
al., 2001; Hammond, 2016). Studies that have characterized the bovine vaginal
bacterial community profiles reported that Pseudomonadaceae, the family in which
8

Pseudomonas aeruginosa belong, is present within the vaginal cavity (LaguardiaNascimento et al., 2015), but the prevalence of this particular bacterial is not well
characterized in bovine. Padula and Macmillan (2006) performed an experiment to
examine the effect of CIDR (1.9 g progesterone) insertion on bacterial isolates found
within the vagina of postpartum Holstein cows. The study was designed such that three
treatments were administered (control: no CIDR; CIDR-P4: two intravaginal devices
containing progesterone were administered for 14 d; CIDR-Blank: two intravaginal
devices without progesterone were administered for 14 d) and vaginal swabs were
performed on d 0 (day of CIDR insertion), 7, and 14 to examine culturable bacterial
profiles (Padula and Macmillan, 2006). Additionally, CIDRs were swabbed immediately
after removal on d 14 to determine bacterial species present on the device. For both
CIDR treatment groups, the number of samples positive for Pseudomonas aeruginosa
increased over the sampling period. Likewise, among the samples collected on d 7 and
14, the presence of Pseudomonas aeruginosa was greater in the CIDR-P4 treated cows
when compared to the other two treatment groups (Padula and Macmillan, 2006).
Pseudomonas aeruginosa isolates were also present within the cultures obtained from
swabbing the CIDR directly after removal. Padula and Macmillan (2006) indicated there
was a potential for cross-contamination between animals, but regardless of
contamination, the presence of Pseudomonas aeruginosa increased as a result of CIDR
insertion.
Although it appears that progesterone released from a CIDR may impact the
population of Pseudomonas aeruginosa within the vaginal cavity, further investigation is
9

warranted to dismiss the possibility of contamination (Padula and Macmillan, 2006).
Furthermore, the exposure of the vaginal cavity to air during the duration of CIDR
insertion may have contributed to the shift in aerobic bacterial populations (Padula and
Macmillan, 2006). We suggest that subsequent studies should aim to examine the
effect of one CIDR on the vaginal bacterial profiles as only one insert is used in
traditional estrous synchronization protocols. Recognizing that only CIDRs containing
1.38 g of progesterone are approved for use in the United States, further investigation is
justified to determine if CIDRs impregnated with 1.38 g of progesterone elicit a similar
pattern to those observed by Padula and Macmillan (2006).
Influence of Pseudomonas aeruginosa on steroid hormone bioavailability
Pseudomonas aeruginosa has the capability to synthesize and release LasB
(Pseudomonas aeruginosa elastase), a protease that can cleave the reactive center
loop (RCL) of the steroid hormone transporter, corticosteroid-binding globulin (CBG)
(Simard et al., 2014; Hammond, 2016). When Simard et al. (2014) incubated human
CBG in a variety of bacterial cultures (Pseudomonas aeruginosa, Eschericha coli,
Staphylococcus aureus, Burkholderia cenocepacia, Micrococcus luteus, Enterococcus
faecalis, Acinetobacter baumannii, and Mycobacterium smegmatis) they observed a 90
% reduction in the cortisol-binding capacity and a 5-10 kDa loss when CBG was
incubated in Pseudomonas aeruginosa medium. No other bacterial cultures affected
the cortisol-binding capacity of CBG. When human CBG was incubated with protease
fractions extracted from Pseudomonas aeruginosa, only LasB reduced the cortisol10

binding capacity of CBG and proved to have the ability to interfere with the ability of
CBG to bind steroids within the RCL (Simard et al., 2014). Based on the study
performed by Simard et al. (2014) and the presence of Pseudomonas aeruginosa in the
bovine vaginal cavity as reported by Padula and Macmillan (2006), further investigation
is warranted to determine if this particular bacteria has the ability to influence CBG and
free progesterone concentrations during the estrous synchronization process.
Overview of corticosteroid-binding globulin (CBG) in circulation
Corticosteroid-binding globulin is a glycoprotein that is primarily synthesized
within hepatocytes (Hammond et al., 1991; Heo et al., 2003a) and functions as a
transporter for a small subset of steroid hormones (i.e. glucocorticoids and
progesterone) in which it binds with high affinity, but low capacity (Slaunwhite and
Sandberg, 1959; Seal et al., 1966; Westphal, 1986a; Heo et al., 2003b). Corticosteroidbinding globulin is a member of the serine protease inhibitor superfamily (Hammond et
al., 1987; Law et al., 2006) and acts as a target for proteases (Lin et al., 2010) such as
neutrophil elastase (Hammond et al., 1990), chymotrypsin (Lewis and Elder, 2014), and
LasB, a protease produced and released by the bacterial species, Pseudomonas
aeruginosa (Simard et al., 2014). In the presence of CBG, the aforementioned
proteases cleave specific sites within the RCL of CBG and compromise the steroid
binding capacity (Lewis and Elder, 2017). After cleavage, the steroid dissociates from
CBG and can be sequestered and loosely bound by albumin, or remain free within
circulation, but in both instances the steroid is considered biologically available (Simard
11

et al., 2014). Additionally, a consequence of RCL cleavage includes a 5 kDa reduction
in molecular weight and conformational change that prevents the ability of CBG to bind
an additional steroid molecule (Hammond et al., 1990; Potempa et al., 1994; Silverman
et al., 2001).
Free hormone hypothesis and steroid hormone distribution
The free hormone hypothesis suggests that steroid hormones in the unbound or
free-state are considered biologically available and are able to passively diffuse from
the vasculature to specific effector tissues to serve their respective physiological
functions (Siiteri et al., 1981; Mendel, 1989; Hammond, 2016). A limitation that exists
within the current literature is that many experiments with the aim to examine
fluctuations in cortisol or progesterone, as a result of an imposed treatment, often do not
take into consideration CBG concentration. Consequently, this approach only provides
insight into the production of the steroid, not alterations in the biologically available, or
active fraction of the steroid. The free cortisol index (FCI; nmol/mg) is a calculation that
was derived to quantify biologically available cortisol concentrations and is determined
by examining the ratio of circulating cortisol concentration (nmol/L) in relation to CBG
concentration (mg/L) (Le Roux et al., 2002; Le Roux et al., 2003). The use of this
calculation allows for the estimation of cortisol that is biologically active in systemic
circulation and is a better depiction of hypothalamic-pituitary-adrenal axis stimulation
(Le Roux et al., 2003).
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In humans, approximately 80 to 90 % of cortisol is bound to CBG, 5 to 10 % is
loosely bound to albumin, and 5 % exists as free or completely unbound in circulation
(Siiteri et al., 1982; Hammond et al., 1991; Estrada-Y-Martin and Orlander, 2011).
Aside from humans, the distribution of cortisol has been documented in other species
(Breuner and Orchinik, 2002; Malisch and Breuner, 2010), but little has been reported
for domestic livestock species. Our lab has previously examined the distribution in
swine, and similar to humans, CBG is the primary protein transport for cortisol in swine,
but it is estimated that approximately 65 % is bound to CBG, 23 % bound to albumin,
and 12 % free in systemic circulation (Kattesh et al., 1990; Kattesh et al., 1997). Among
species, the RCL amino acid sequence is poorly conserved as compared to the overall
amino acid sequence of the glycoprotein (Simard et al., 2014), and may contribute to
the variability in the distribution of steroids observed among species. Nonetheless,
CBG acts as the primary transporter of cortisol in circulation.
Thus far, progesterone distribution has not been as well characterized in the
literature as compared to cortisol. However, research aiming to evaluate the proportion
of free and bound progesterone fractions have been investigated in regards to
pregnancy. In a study conducted by Rosenthal et al. (1969) where free and bound
fractions of progesterone are measured during the trimesters of human pregnancy, it
appears that CBG acts a buffer to limit the amount of free progesterone throughout the
course of pregnancy. More specifically, the authors noted that CBG-bound
progesterone increases from 37 to 43 %, whereas free progesterone is maintained at
approximately 2 % throughout pregnancy (Rosenthal et al., 1969). The rise in CBG13

bound progesterone was concurrent with the overall rise in circulating progesterone
concentrations throughout the three trimesters and it appears that the proportion of
CBG-bound progesterone is concentration dependent (Rosenthal et al., 1969).
Additionally, by the second trimester CBG became the primary transporter for
progesterone (Rosenthal et al., 1969), is believed to function as a buffer to regulate the
amount of free progesterone in circulation, extend the half-life, and to create a reserve
of the steroid (Siiteri et al., 1982; Bright, 1995; Klieber et al., 2007).
Reproductive functional roles of CBG
Glucocorticoids and progesterone compete for the one binding site CBG harbors
within its RCL, and the concentration of cortisol or progesterone can alter the ratio of
steroids bound within the RCL (Westphal, 1986a). For example, under periods of high
progesterone production during human pregnancy, progesterone displaces cortisol from
the RCL to occupy the binding site (Rosenthal et al., 1969); whereas, during periods of
elevated glucocorticoid production, cortisol displaces progesterone from the RCL
(Westphal, 1986a). This interaction signifies the main function of CBG which includes
serving as a buffer and reservoir for glucocorticoids and progesterone (Rosner, 1991;
Sivukhina and Jirikowski, 2014).
Regulatory role of CBG during pregnancy
The role of CBG in reproductive function still remains unclear, but previous
research conducted in the field of human reproduction has revealed that CBG likely
assumes the role of regulating the bioavailability of steroids at the maternal-fetal
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interface throughout the course of pregnancy (Benassayag et al., 2001; Hammond,
2016). In support of this claim, Benassayag et al. (2001) examined concentrations of
cortisol, progesterone, CBG, and albumin within maternal circulation, intervillous blood,
the umbilical vein, and umbilical arteries at time of delivery in women with normal, fullterm pregnancies (Benassayag et al., 2001). The authors noted no differences in
albumin concentration among the 4 vascular sampling locations, and circulating albumin
concentrations in pregnant women were similar to that of non-pregnant controls
(Benassayag et al., 2001). However, concentrations of CBG were different among the
sampling locations. Maternal peripheral samples contained the greatest concentration
of CBG, and CBG concentration in the intervillous blood space was greater than those
measured within the umbilical vein and arteries (Benassayag et al., 2001). Peripheral
concentrations of CBG were approximately three times greater in full-term pregnant
women when compared to the non-pregnant controls (Benassayag et al., 2001).
Interestingly, concentrations of progesterone and cortisol also varied greatly among the
4 sampling locations. Progesterone was the greatest in the intervillous space and
lowest in peripheral circulation, but the opposite was observed for cortisol (Benassayag
et al., 2001). It is likely that the differences in CBG concentration between peripheral
and intervillous circulation are a reflection of the steroid load in those particular sites.
Additionally, the authors hypothesized that CBG within the intervillous space functions
as a transporter of progesterone from the maternal vasculature to the fetal placenta
(Benassayag et al., 2001). Because of greater concentrations of CBG within the
intervillous space when compared to the umbilical vein and arteries, and distinct varying
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isoforms between maternal and fetal CBG, it appears that maternal-derived CBG is the
primary source of CBG at the maternal-fetal interface (Benassayag et al., 2001).
Furthermore, it is suggested that the elevated CBG concentration in maternal circulation
act to buffer the greater cortisol concentrations associated with pregnancy, and to
prevent the transfer of this steroid to fetal circulation (Murphy, 1979; Westphal, 1986b;
Benassayag et al., 2001), but also to prevent the maternal development of
hypercorticism (Sandberg et al., 1966).
Role of CBG in transport of progesterone
In addition to steroid buffering, CBG may also play a role in transporting
progesterone from the corpus luteum (CL) to the uterus (Graham and Clarke, 1997),
but, the exact mechanism of action is not well understood. The presence of CBG
mRNA in steroidogenic tissues, and specifically within both the human corpus luteum
and endometrium supports the theory that CBG plays a role in progesterone transport
and steroidogenic function (Misao et al., 1994; Misao et al., 1997; Misao et al., 1999).
Misao et al. (1997) examined the expression of CBG mRNA in human CL tissue
following hysterectomy procedures and reported a greater expression of CBG mRNA
during the mid-luteal phase of the menstrual cycle when compared to the early and lateluteal phases when concentrations of progesterone are lower than that of the mid-luteal
phase (Misao et al., 1997; Misao et al., 1999). Similarly, CBG mRNA levels are higher
during the secretory phase of the menstrual cycle, a phase characterized by greater
progesterone concentrations when compared to the proliferative phase (Misao et al.,
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1994). Therefore, it is speculated that CBG may play a role in the localized transport of
progesterone within the reproductive tract of humans, but to the best of our knowledge,
no other mechanisms have been proposed, and this relationship has not been
examined in regards to the bovine estrous cycle.
Regulatory role of CBG during parturition
In addition to endometrial and luteal production, CBG can be found in other
tissues with glucocorticoid or progesterone demands. However, similar to other steroid
transporter proteins such as albumin and sex hormone-binding globulin, CBG is
predominantly synthesized within hepatocytes (Khan et al., 1984), and has been
reported in many species including humans (Khan et al., 1984), swine (Heo et al.,
2003a), rats (Weiser et al., 1979), guinea pigs (Perrot-Applanat et al., 1981), and rabbits
(Seralini et al., 1990). Previous work conducted in our lab indicated that CBG
biosynthesis changes throughout the course of an individual’s life and is related to
physiological events that occur during that particular phase of development (Heo et al.,
2003b). For example, fetal hepatic CBG mRNA levels decrease toward the end of
gestation and was reflected by an overall reduction in plasma CBG concentrations, but
the reverse is observed following birth through the first 40 d of the post-natal period
when CBG mRNA levels and plasma CBG concentration were greater than those
observed at the time of birth (Heo et al., 2003b). In humans, the heightened production
and release of fetal glucocorticoids (i.e. cortisol) near the end of gestation plays a vital
role in preparing the fetus and dam for birth by aiding in fetal lung maturation (Smith,
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2007), and upregulating estradiol and pro-inflammatory prostaglandin production to
stimulate uterine myometrial contractions (Whittle et al., 2001). Therefore, it is likely
Heo et al. (2003b) observed a reduction in hepatic CBG production at the time of birth to
allow for an increase in free, or biologically active cortisol associated with the parturition
process. Furthermore, it is hypothesized that the overall rise in circulating CBG
concentration toward the end of gestation limits negative feedback on the hypothalamus
and anterior pituitary to allow for continued hypothalamic-pituitary-adrenal (HPA) axis
activation necessary for parturition (Ballard et al., 1982; Challis and Brooks, 1989;
Berdusco et al., 1995).
Factors that influence CBG biosynthesis
Glucocorticoids
Glucocorticoids, interleukin-6 (IL-6), and estradiol are three main proposed
factors that are capable of regulating CBG biosynthesis. In many species, periods in
which an individual experiences stress and is under heightened glucocorticoid (i.e.
cortisol) influence are often associated with an overall reduction in circulating CBG
concentration (Kattesh et al., 1980; Heo et al., 2005; Ho et al., 2006). Previously it has
been reported that the glucocorticoid receptor (GR), in conjunction with its ligand,
regulates the transcription of the CBG promotor in mice and rats (Smith and Hammond,
1992; Cole et al., 1999), but until recently the full mechanism in which glucocorticoids
regulate CBG biosynthesis was not understood. Verhoog et al. (2014) were the first to
describe the mechanism for which glucocorticoids suppress CBG biosynthesis though a
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series of in vivo and in vitro experiments. First, male mice (n = 40) were subjected to
four treatments for the duration of 10 d that included the following: no treatment
(control), voluntary exercise, involuntary swimming (1 hr/d), and restraint in a small cage
(1 hr/d). After the 10 d period, mice were sacrificed and livers were harvested and used
to evaluate CBG mRNA expression. When compared to the control mice, the mice in
the stress-related treatment groups (involuntary swimming and restraint) had a 27 and
55 % reduction in CBG mRNA expression, respectively (Verhoog et al., 2014). Next,
the authors exposed human (HepG2) and mouse (BWTG3) hepatoma cells to
dexamethasone (1 nM), a synthetic glucocorticoid, and reported a reduction in both
CBG mRNA expression and CBG protein levels within both cell types which indicated
that glucocorticoids are capable of hindering CBG biosynthesis at the transcriptional
level (Verhoog et al., 2014).
To verify that dexamethasone suppression of CBG biosynthesis acts through the
GR, Verhoog et al. (2014) then examined the effect of dexamethasone on CBG
promoter reporter constructs transfected within mouse hepatoma cells and reported a
dose-dependent reduction in promotor activity within the cells. Additionally, they
reported a heightened suppressive effect on promoter activity occurred when the
hepatoma cells were co-transfected with GRα and incubated with dexamethasone
(Verhoog et al., 2014). Similar to results reported by Cole et al. (1999), in which
dexamethasone suppression act by way of the GR, when hepatoma cells were cotransfected with RU486, an antagonists of the GR, the suppressive effect of
dexamethasone was nullified, indicating that glucocorticoids inhibit CBG biosynthesis
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though interactions with the GR (Verhoog et al., 2014). More specifically, the authors
reported that glucocorticoids cause a migration of C/EBPβ, a transcription factor, to the
proximal promoter of the CBG gene (SerpinA6) to repress CBG transcription (Verhoog
et al., 2014).
Previously, Underhill and Hammond (1995) showed that C/EBPβ has the
capability to bind to the promotor region on the CBG gene. To further support this claim,
Verhoog et al. (2014) performed an experiment in which C/EBPβ was knocked-down in
mouse hepatoma cells and reported a reduction in the ability of dexamethasone to
repress CBG mRNA expression when C/EBPβ protein expression was reduced.
Similarly, the migration of the GR to the proximal promotor region of the CBG gene was
reduced (Verhoog et al., 2014). All together, these results indicate that CBG
biosynthesis is controlled in part by glucocorticoids and their receptor and it appears
that the mechanism controlling CBG biosynthesis lies at the transcriptional level where
the glucocorticoid activated GR, in conjunction with C/EBPβ, bind to the promotor of the
CBG gene and represses CBG transcription (Verhoog et al., 2014).
Interleukin-6
Unlike other acute phase cytokines, IL-6 has the ability to regulate hepatic CBG
biosynthesis (Bartalena et al., 1993; Emptoz-Bonneton et al., 1997). Interleukin-6, a
pro-inflammatory acute phase cytokine produced by leukocytes, has the ability to
suppress hepatic CBG biosynthesis in a dose-dependent manner, and the mechanism
as to which it is able to regulate CBG biosynthesis is similar to that of glucocorticoids
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(Emptoz-Bonneton et al., 1997). In HepG2 cells, IL-6 caused a 71 and 61 % reduction
in the secretion of the glycoprotein and the expression of CBG mRNA, respectively
which indicates that IL-6 is a transcriptional regulator of the CBG gene (EmptozBonneton et al., 1997; Perogamvros et al., 2012). In support of this claim, Underhill and
Hammond (1995) previously reported that IL-6 suppressed the transcriptional process
of the rat CBG gene by interacting with C/EBPβ, the transcription factor involved in
glucocorticoid-induced transcriptional inhibition process mentioned above. As a result
of IL-6 and glucocorticoids sharing the same mechanism for inhibiting hepatic CBG
biosynthesis, there is an accumulative suppressive effect when HepG2 cells are
cultured in the presence of both IL-6 and dexamethasone (Emptoz-Bonneton et al.,
1997).
An in vivo study performed in men elicited a similar response to the in vitro study
mentioned above. A single administration of IL-6 at a concentration of 3.0 µg/kg caused
a decline in circulating CBG concentrations and one week post-treatment was required
before baseline concentrations of CBG were observed (Tsigos et al., 1998). It is
noteworthy to mention that the authors chose a dose of 3.0 µg/kg to ensure HPA axis
activation to mimic the response that would be observed during periods of septic shock
or trauma which have also been associated with reduced CBG concentrations (Tsigos
et al., 1998; Ho et al., 2006). The inverse relationship observed between CBG
biosynthesis and IL-6 supports the idea that CBG acts as a negative acute phase
protein to increase the bioavailable fraction of cortisol in circulation as a way to mediate
the inflammatory response (Tsigos et al., 1998; Perogamvros et al., 2012).
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The role of CBG as a negative acute phase protein is important for its role in the
mitigation of the inflammatory response (Hammond et al., 1990; Perogamvros et al.,
2012). As mentioned earlier, in the presence of neutrophils, a particular group of
leukocytes that respond during the innate immune response to inflammation, CBG
undergoes a 5 kDa reduction in molecular weight and a loss to its steroid-binding
capacity (Hammond et al., 1990). The reduction in binding capacity of CBG allows for
targeted delivery of glucocorticoids to sites of inflammation and localized immune cells
(Hammond et al., 1990; Perogamvros et al., 2012). Neutrophils are one of the first
responders to sites of inflammation and are responsible for targeting invading
pathogens and for the release of reactive oxygen species, but under periods of chronic
inflammation, these actions can be harmful and lead to tissue destruction (Nathan,
2006; Mantovani et al., 2011). Glucocorticoids such as cortisol serve as immune
regulators by suppressing the inflammatory response through a direct interaction with
neutrophils at the site of inflammation (Hammond et al., 1990). Once cortisol is cleaved
from the RCL of CBG, dissociates from the transport protein, and is taken up by
neutrophils, the steroid is able to alter gene expression within the immune cell and to
reduce the release of reactive oxygen species (Burton et al., 2005; Buckham Sporer et
al., 2007). Therefore, in regards to periods of inflammation, it is evident that IL-6
induced cortisol release occurs to prevent the negative effects of prolonged
inflammation and to regulate the localized immune response. Furthermore, CBG can
be classified as a negative acute phase protein because hepatic CBG expression is
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reduced during inflammation to allow for greater levels of bioavailable glucocorticoids
(Pugeat et al., 1989).
Estrogen
Unlike glucocorticoids and IL-6, estrogen increase hepatic CBG biosynthesis and
elevations in CBG concentration are associated with the administration of oral
contraceptives, but to the best of our knowledge the mechanism of action is not
presently understood. Previously, Doe et al. (1967) conducted an experiment to
examine the effect of oral administration of diethylstilbestrol, a synthetic estrogenic
compound, on fluctuations in CBG concentration in a test male patient undergoing
treatment for prostate cancer. Diethylstilbestrol was administered daily (1 mg/d) for 4
weeks followed by a period of 4 weeks in which no treatment was administered. The
dose was then increased by 1 mg/d and the treatment schedule repeated until a
maximum dose of 5 mg/d was achieved. Over the treatment period, circulating
concentrations of CBG increased in a dose-dependent manner, but following the
treatment period, a withdrawal period of 4 weeks was required to return CBG
concentrations back to baseline levels (Doe et al., 1967). Similarly, other studies have
reported an increase in circulating CBG concentrations following administration of
diethylstilbestrol and ethinylestradiol in women (Sandberg and Slaunwhite, 1959), and a
two-fold increase in hepatic production rate of CBG following estradiol administration in
male rats (Feldman et al., 1979). Therefore, it appears that estrogenic compounds are
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capable of increasing circulating CBG concentrations by directly stimulating hepatic
CBG biosynthesis.
More recently, Ågren et al. (2011) administered combined oral contraceptives to
women to investigate the impact of estrogen and progestin-based contraceptive drugs
on circulating levels of CBG. The experimental subjects ranged from 18 to 50 years of
age and were stratified into two treatment groups that received one of the following
treatments for six 28-d cycles: nomegestrol acetate/17β-estradiol (2.5 mg/1.5 mg;
NOMAC/E2) or levonorgestrel/ethinylestradiol (150 µg/30 µg; LNG/EE) (Ågren et al.,
2011). Blood samples were collected prior to the start of the study and during cycles 3
and 6 to examine changes to CBG concentration. Both treatment groups exhibited
greater CBG concentrations at the end of the study when compared to the baseline
sample collected. Women within the NOMAC/E2 treatment group experienced a 27 %
(910 vs. 1116 nmol/L) increase in CBG concentration, but this rise was far less than that
observed in the LNG/EE treatment group which had an overall increase of 118 % (932
vs. 1980 nmol/L) (Ågren et al., 2011). Differences in the overall rise in CBG
concentration observed at the end of the experiment are attributed to the different
estrogenic compounds used in the two treatments (Zeun et al., 2009; Ågren et al.,
2011). Nonetheless, circulating CBG concentrations rise as a result of heightened
hepatic biosynthesis during periods of estrogen influence, but are not affected by the
progestin compound in the combined oral contraceptive drug (Hammond et al., 1984).
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Conclusion
Although the role of CBG in regards to the regulation of glucocorticoids at various
stages of life have been well documented in a variety of species, an overall lack in
knowledge remains in regards to the interaction between CBG and the steroid
hormones it transports in the bovine specifically. Additionally, the role of CBG in
reproductive-specific events and the transport of progesterone remains unclear and
further investigation is warranted. Recognizing that the use of estrous synchronization
has become a common cattle management practice and the majority of protocols rely
on the use of a CIDR, an opportunity exists to explore the effect of exogenous
progesterone administration on local vaginal and systemic concentrations of CBG.
Likewise, delving into this response will help us to better understand the role of CBG as
a transporter and buffer for progesterone within the bovine reproductive tract.
Furthermore, the opportunity exists to examine CBG synthesis sites within the
bovine reproductive tract. As mentioned previously, CBG mRNA is expressed in
reproductive tissues of a variety of species, but has not been examined in cattle. In
other species, the presence of CBG within in the uterus has been documented (Milgrom
and Baulieu, 1970; Klemcke et al., 1998), but to the best of our knowledge,
concentrations within the vaginal cavity have not been measured. Evaluating CBG
mRNA expression within the vagina, uterus, oviduct, and ovary in conjunction with
directly measuring concentrations of CBG within the reproductive tract will indicate if the
glycoprotein is locally produced or shuttled to the reproductive tract from the vascular
system or via migration from other regions within the tract.
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Realizing that Pseudomonas aeruginosa is a common environmental bacterial
pathogen and its colonization within the bovine vaginal cavity appears to be influenced
by exogenous progesterone release from a CIDR (Padula and Macmillan, 2006), further
investigation is warranted to determine if the presence of this particular bacteria within
the vaginal cavity has an influence on the level of free, or biologically available
progesterone during the estrous synchronization process, or pregnancy success
following fixed-time artificial insemination. Therefore, the goal of the present
dissertation was to investigate the vaginal endocrine response and associated bacterial
interactions in beef heifers undergoing synchronization of ovulation to gain a better
understanding of the direct impact of CIDRs used to facilitate synchrony. Additionally,
this dissertation aimed to characterize CBG synthesis in the female bovine reproductive
tract and examine changes in CBG mRNA expression during different stages of the
estrous cycle and gestation. Through the completion of these experiments, the
expected outcome was to gain a better understanding of bovine CBG and its influence
on the reproductive axis, but to also gain insight as to the local production of CBG within
the bovine reproductive tract.
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Chapter II
Influence of synchronization of ovulation and early pregnancy on
peripheral and vaginal concentrations of corticosteroid-binding
globulin and the distribution of progesterone and cortisol in beef
heifers
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Abstract
Corticosteroid-binding globulin (CBG) is a transporter for glucocorticoids (i.e.
cortisol) and progesterone and functions to regulate the amount of free steroid in
circulation, but little is known about CBG and its role in bovine reproductive function.
The objective of this study was to examine the effect of exogenous progesterone
release from a controlled internal drug release device (CIDR) on circulating and vaginal
concentrations of CBG and the proportion of free progesterone and cortisol following
synchronization of ovulation using the 7 d CO-Synch + CIDR protocol. Consigned beef
heifers (n = 67) were enrolled in the study and on d -7, immediately prior to CIDR
insertion, blood and vaginal flush samples were collected. Following CIDR removal on
d 0, the same samples were collected again. Blood samples were collected for a third
time at the time of pregnancy diagnosis on d 38. Steroid concentrations were
determined using a commercially available RIA and CBG was quantified by an in-house
ELISA. Steroid hormone concentration (nmol/L) was then divided by CBG
concentration (mg/L) to calculate a free hormone index (nmol/mg) for both progesterone
(FPI) and cortisol (FCI). A mixed model analysis of variance with repeated measures
was performed. Plasma samples collected at pregnancy diagnosis on d 38 from heifers
with successful pregnancies (n = 24) following synchronization and AI had greater (P =
0.02) concentrations of progesterone than samples collected d -7, but were not different
than those measured on d 0. Similarly, plasma CBG concentrations measured on d -7
and 0 did not differ, but were greatest (P = 0.03; n = 24) on d 38. The FPI calculated
from progesterone and CBG concentrations measured on the three sampling days were
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not different (P = 0.16). Similar to plasma progesterone concentrations, circulating
concentrations of cortisol were consistent during synchronization of ovulation (d -7 and
0), but were lower (P = 0.01; n = 24) at pregnancy diagnosis (d 38). Likewise, FCI did
not change during synchronization of ovulation, but was lowest (P < 0.0001; n = 24) at
pregnancy diagnosis on d 38. Among heifers that became pregnant following AI,
progesterone concentrations contained within vaginal flush samples collected
immediately after CIDR removal on d 0 were approximately four times greater (P <
0.0001) than concentrations measured immediately prior to CIDR insertion on d -7, but
CBG concentrations measured on d -7 were not different (P = 0.21) from those
measured on d 0, and thus, the FPI on d 0 was greater (P < 0.0001) than on d -7.
Vaginal cortisol concentrations measured immediately following CIDR removal were
approximately two times greater (P < 0.0001) than those measured before the CIDR
was inserted. Similarly, vaginal FCI was greater (P < 0.0001) at CIDR removal than at
CIDR insertion. In the current study, CIDR insertion did not affect circulating CBG
concentrations, but it appears that CBG may play a role in regulating the free fraction of
progesterone during early gestation.
Introduction
Estrous synchronization relies on coordinated administration of exogenous
reproductive hormones and many of the protocols developed and approved for use in
the United States rely on the use of a controlled internal drug release device (CIDR). In
contrast to other exogenous hormones that are administered by injection, CIDRs are
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plastic devices that are infused with progesterone (1.38 g) and after intravaginal
insertion, progesterone is absorbed through the vaginal epithelium and migrates to the
vascular system. Within 1 h post-insertion, circulating concentrations of progesterone
reach a maximum peak (approximately 4.5 ng/mL) and are sustained throughout a 7 d
insertion period (Kesler, 2002). Similar to the rapid rise in systemic progesterone
concentration after insertion, systemic progesterone rapidly decreases after the CIDR is
removed and returns to baseline concentrations 8 h post-removal (Kesler, 2002).
Insertion of a CIDR for a period of 7 d ensures the corpus luteum (CL) has
reached maturity and can undergo luteolysis following PGF2α administration (Lucy et al.,
2001; Kesler, 2002). Likewise, during the CIDR insertion period, the low dose release
of progesterone prevents follicular wave turn-over and promotes the development of a
persistent dominant follicle by increasing luteinizing hormone (LH) pulse frequency
(Savio et al., 1993; Kojima et al., 2003). As the persistent follicle continues to develop,
estradiol production and release subsequently increases (Kojima et al., 2003). Through
positive feedback on the hypothalamus, estradiol promotes the release of gonadotropinreleasing hormone (GnRH) and subsequent LH production and release from the
anterior pituitary gland (Kesner et al., 1981), and in pre-pubertal heifers and anestrous
cows this mechanism allows for initiation or resumption of cyclicity (Anderson et al.,
1996; Imwalle et al., 1998).
Corticosteroid-binding globulin (CBG) is a glycoprotein that is predominantly
synthesized within hepatocytes (Hammond et al., 1991; Heo et al., 2003a) and functions
as a transporter for a small subset of steroid hormones (i.e. glucocorticoids and
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progesterone) in which it binds with high affinity, but low capacity (Slaunwhite and
Sandberg, 1959; Seal et al., 1966; Westphal, 1986a; Heo et al., 2003b). Corticosteroidbinding globulin is a member of the serine protease inhibitor superfamily (Hammond et
al., 1987; Law et al., 2006), and acts as a target for proteases (Lin et al., 2010) such as
neutrophil elastase, a protease specifically synthesized and released by neutrophils
(Hammond et al., 1990). More recently chymotrypsin, and LasB, an elastase produced
and released by the bacterial species, Pseudomonas aeruginosa have also been
reported as proteases capable of disrupting the reactive center loop (RCL) (Lewis and
Elder, 2014; Simard et al., 2014). In the presence of CBG, the aforementioned
proteases cleave specific sites within the RCL of CBG and compromise the steroid
binding capacity (Lewis and Elder, 2017). After cleavage, the steroid dissociates from
CBG and can be sequestered and loosely bound by albumin, or remain free within
circulation, but in both instances the steroid is considered biologically available (Simard
et al., 2014).
In humans, approximately 80 to 90 % of cortisol is bound to CBG, 5 to 10 % is
loosely bound to albumin, and 5 % exists as free or completely unbound in circulation
(Siiteri et al., 1982; Hammond et al., 1991; Estrada-Y-Martin and Orlander, 2011).
Aside from humans, the distribution and characterization of cortisol has been
documented in other species (i.e. wild birds, chimpanzees, gorillas, rats, chickens, etc.)
(Gayrard et al., 1996; Breuner and Orchinik, 2002; Malisch and Breuner, 2010), but little
has been reported for domestic livestock species. Our lab has previously examined the
distribution in swine, and we estimated that approximately 65 % is bound to CBG, 23 %
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bound to albumin, and 12 % free in systemic circulation (Kattesh et al., 1990; Kattesh et
al., 1997).
Thus far, progesterone distribution has not been as well characterized in the
literature as compared to cortisol. However, research aiming to evaluate the proportion
of free and bound progesterone fractions have been investigated in regards to human
pregnancy. In a study conducted by Rosenthal et al. (1969) where free and bound
fractions of progesterone are measured during the trimesters of human pregnancy, it
appears that CBG acts a buffer to limit the amount of free progesterone throughout the
course of pregnancy. More specifically, the authors noted that CBG-bound
progesterone increases from 37 to 43 %, whereas free progesterone is maintained at
approximately 2 % throughout pregnancy (Rosenthal et al., 1969). The rise in CBGbound progesterone was concurrent with the overall rise in circulating progesterone
concentrations throughout the three trimesters and it appears that the proportion of
CBG-bound progesterone is concentration dependent (Rosenthal et al., 1969).
Additionally, by the second trimester CBG became the primary transporter for
progesterone (Rosenthal et al., 1969), is believed to function as a buffer to regulate the
amount of free progesterone in circulation, extend the half-life, and to create a reserve
of the steroid (Siiteri et al., 1982; Bright, 1995; Klieber et al., 2007).
The free hormone hypothesis suggests that steroid hormones in the unbound or
free-state are considered biologically available and are able to passively diffuse from
the vasculature to specific effector tissues to serve their respective physiological
functions (Siiteri et al., 1981; Mendel, 1989; Hammond, 2016). The free cortisol index
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(FCI; nmol/mg) is a calculation that was derived to quantify biologically available cortisol
concentrations and is determined by examining the ratio of circulating cortisol
concentration (nmol/L) in relation to CBG concentration (mg/L) (Le Roux et al., 2002; Le
Roux et al., 2003). The use of this calculation allows for the estimation of cortisol that is
biologically active and is a better indicator of hypothalamic-pituitary-adrenal axis
activation (Le Roux et al., 2003). For this manuscript, we also adapted this calculation
to estimate the proportion of biologically available progesterone.
Recognizing that the use of estrous synchronization has become a common
cattle management practice and the majority of protocols rely on the use of a CIDR, an
opportunity exists to explore the effect of exogenous progesterone administration on the
local vaginal and systemic endocrine response. Therefore, the goal of the present
study was to investigate vaginal steroid hormone profiles and systemic endocrine
response in beef heifers undergoing synchronization of ovulation using the 7 d COSynch + CIDR protocol to gain a better understanding of the direct impact of CIDRs
used to facilitate synchrony on CBG concentrations. We hypothesized that CBG
concentrations would rise during synchronization of ovulation to regulate the proportion
of free progesterone in the vaginal cavity and in circulation.
Materials and Methods
Animals
Prior to animal manipulation, procedures were approved by the University of
Tennessee Institutional Animal Care and Use Committee (protocol number 2398-1115).
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Heifers (n = 67) enrolled in the study were consigned to the University of Tennessee
Beef Heifer Development Program in Lewisburg, TN on October 3, 2016 and remained
in the program until September, 2017. At arrival, heifer age and body weight ranged
from 182 to 383 d of age and 198.7 to 390.1 kg, respectively. Breed composition
included the following: Angus (n = 28), Angus x Hereford (n = 4), Angus x Shorthorn (n
= 2), Angus-cross (n = 9), Charolais (n = 7), Gelbvieh (n = 4), Hereford (n = 4),
Simangus (n = 4), and Simmental (n = 5). All heifers were housed on pasture and
received the same feed ration over the course of the program. Ad libitum access to
water and supplemented hay was also provided.
Tissue collection and synchronization of ovulation
Synchronization of ovulation began on March of 2017 when heifers were 416 ±
34 d of age and had an average body weight of 415 ± 36 kg. Heifers enrolled in the
study included those that had not undergone prior synchronization of ovulation
procedures at the testing center. On d -7, immediately prior to the administration of
GnRH (100 ug, Factrel; Zoetis, Madison, NJ) and CIDR (1.38 g progesterone; EaziBreed CIDR, Zoetis, Madison, NJ) insertion as part of the 7 d CO-Synch + CIDR
protocol, blood (6 mL) was collected in sodium heparin vacutainer tubes (Becton
Dickinson, Franklin Lakes, NJ) via coccygeal venipuncture. Blood samples were
centrifuged (Sero-Fuge Centrifuge, Clay Adams, Inc., Parsippany, NJ) for 10 min and
plasma was harvested, aliquoted into three 2 mL microcentrifuge tubes, and then stored
at -20°C until analyzed for total cortisol, progesterone, and CBG concentrations.
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Following blood collection, the vulva was cleaned with 70 % ethanol and vaginal
cytological samples were collected by inserting a cytobrush (Cooper Surgical, Inc.,
Trumbull, CT) into the vaginal lumen and rotating the brush clockwise against the
vaginal epithelium (Stratman et al., 2016). Cytobrushes were rolled onto microscope
slides and slides were allowed to air dry prior to being stained with a modified WrightGiemsa stain (Protocol hema 3 stain set, Fisher Scientific Co, Pittsburgh, PA) (Stratman
et al., 2016). Under 100X magnification, approximately 200 cells were counted to
determine the proportion of polymorphonuclear neutrophils (PMN) to total cells present
on the slide (Ghasemi et al., 2012; Stratman et al., 2016).
Vaginal flushes were also performed on d -7, immediately prior to CIDR insertion.
Briefly, a rubber catheter attached to a 60 mL syringe was inserted into the vagina and
60 mL of 0.9 % sodium chloride sterile saline was infused into the vagina and recovered
via vaginal lavage and caught in a plastic cup, then transferred to a 50 mL conical tube
and immediately stored on ice. Vaginal flush samples were centrifuged at 2,000 rpm
(821 x g; Beckman Coulter Allegra X-14R Centrifuge, Brea, CA) for 5 min at 4°C,
aliquoted into three 13 mL culture tubes, and then stored at -20°C until analyzed for
total cortisol, progesterone, and CBG concentrations as well as bacterial analyses.
The same procedures mentioned above to collect blood, cytological samples,
and perform vaginal swabs and flushes were again performed on d 0 when CIDRs were
removed and PGF2α was administered. On d 2, heifers received another injection of
GnRH immediately prior to AI. An additional blood sample for progesterone, cortisol,
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and CBG analyses was obtained at time of pregnancy diagnosis (d 38) as determined
by transrectal ultrasonography.
Plasma steroid hormone analyses
Total plasma cortisol and progesterone concentrations (ng/mL) were measured
in duplicate by following the procedures of commercially available RIA kits (MP
Biomedicals, Solon, OH; cat # 07-221102 and 07-170102, respectively) (Hulbert et al.,
2013; Pohler et al., 2016). Cortisol standards ranged from 5 to 1,000 ng/mL with a
cross-reactivity less than 12.3 % for related endogenous steroids. Intra- and inter-assay
CV were 17.3 % and 25.9 % for low (2.27 ng/mL) and, 12.2 % and 15.0 % for high (16.2
ng/mL) cortisol controls. Progesterone standards ranged from 0.2 to 50 ng/mL with a
cross-reactivity less than 5.4 % for related endogenous steroids. Intra- and inter-assay
CV were 6.7 % and 6.0 % for low (0.89 ng/mL) and, 11.3 % and 15.1 % for high (5.0
ng/mL) progesterone controls.
Vaginal flush steroid hormone analyses
Total progesterone concentrations within the vaginal flush samples were
determined by following the same RIA procedures as described for the progesterone
measured in plasma samples, but an initial validation was performed to ensure
concentrations of progesterone in the flush samples were within the limits of the
standard curve of the assay. Briefly, vaginal flush samples collected on d -7
(immediately prior to CIDR insertion) and d 0 (immediately post-CIDR removal) from
four random heifers were used for the validation. Undiluted samples from d -7 and 0
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were analyzed for each heifer. Additionally, dilutions of 300 uL sample:100 uL saline,
200 uL sample:200 uL saline, and 100 uL sample:300 uL saline were performed to
determine if dilutions were necessary to ensure sample concentrations fit within the
standard curve of the assay. Based on the results of the validation (Table 1),
concentrations of the undiluted d -7 samples and the diluted (100 uL sample: 300 uL
saline) d 0 samples fit within the standard curve of the progesterone RIA. Samples were
measured in duplicate and intra- and inter-assay CV were 3.6 % and 3.3 % for low (5.93
ng/mL) and, 3.4 % and 5.7 % for high (51.0 ng/mL) progesterone controls.
A two-step validation process was performed for measuring cortisol within the
vaginal flush samples. Concentrations within the samples were too low to be measured
using the same RIA kit that was used for plasma cortisol concentrations. Therefore, we
tested the efficacy of the High Sensitivity Salivary Cortisol Enzyme Immunoassay (EIA)
Kit (Salimetrics, Inc., State College, PA) in regards to measuring cortisol within the flush
samples. The first step of the validation included a recovery assay to determine the
recovery capability of Sep-Pak Classic C18 Cartridges (Waters Corporation, Milford,
MA). We followed the procedures reported by Shackleton and Whitney (1980) for
concentrating urine samples for cortisol determination with slight modification. Instead
of concentrating urinary samples, we concentrated 1 mL of 125I Cortisol Tracer Solution
(MP Biomedicals, Solon, OH; cat # 06B256617), reconstituted in 1 mL of 0.9 % sodium
chloride sterile saline, and measured gamma emissions (counts per minute; cpm) from
the Sep-Pak recovered sample in comparison to 1 mL of straight

125

I Cortisol Tracer

Solution. The straight sample and Sep-Pak recovered sample had gamma emissions of
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47,101.7 cpm and 46,914.7 cpm, respectively, with an overall recovery of 99.6 %. Due
to the high recovery capabilities of the Sep-Pak Classic C18 Cartridges, we continued
with the High Sensitivity Salivary Cortisol EIA validation to determine if concentrations of
cortisol obtained following the use of the cartridges fall within the standard curve of the
assay.
First, we concentrated pre- and post-CIDR flush samples at varying volumes (1,
2, 5, and 10 mL) using Sep-Pak Classic C18 Cartridges as described previously by
Shackleton and Whitney (1980), and then reconstituted in 100 uL 0.9 % sodium chloride
sterile saline. Concentrated samples were then measured for total cortisol
concentration following the manufacturer instructions provided within the Salimetrics
High Sensitivity Salivary Cortisol EIA kit. Based on concentrations obtained after
performing the assay (Table 2), concentrating samples with a volume of 10 mL achieves
concentrations that are within the middle portion of the standard curve (0.12, 0.37, 1.10,
3.30, 10.0, and 30.0 ng/mL). All subsequent vaginal flush cortisol analyses were
performed by concentrating 10 mL of flush sample using the Sep-Pak Classic C18
Cartridges and were quantified in duplicate via the Salimetrics High Sensitivity Salivary
Cortisol EIA with intra- and inter-assay CV of 5.0 and 7.5 % for low (1.17 ng/mL) and
3.3 and 7.8 % for high (9.62 ng/mL) cortisol standards. Within the results section,
concentrations of cortisol within the vaginal flush samples were adjusted for the 10 mL
of flush used to concentrate the samples and are reported as nmol/L.
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CBG concentration determination
Concentrations of bovine CBG (mg/L) were quantified in triplicate by an indirect
competitive ELISA developed previously in our laboratory (Kattesh et al., 2014).
Isolation and purification of CBG from bovine plasma (bCBG) and development and
validation of an ELISA for its quantification followed the procedures outlined by Roberts
et al. (2003) for porcine CBG. Briefly, bovine plasma was collected (~400 ml) and
denuded of bound cortisol by incubation with Amberlite XAD-2 beads (Sigma-Aldrich,
St. Louis, MO), dialyzed against 50 mM Tris, 0.5M NaCl, pH 7.6 (column buffer), and
applied to a Sepharose affinity column containing the ligand 11 -hydroxy-3-one-pregn4-one-17 carboxylic acid (HCAC) (Roberts et al., 2003). The column was washed and
eluted sequentially with column buffer containing 200 ng/mL of cortisol. Fractions
containing CBG were dialyzed again using the same buffer and passed over a 10 mL
Concanavalin A-Sepharose 4B (C9017; Sigma-Aldrich, St. Louis, MO) column (Roberts
et al., 2003). The column was washed and eluted with 10 % and warmed 20 % methyl
-D-mannopyranoside (Sigma-Aldrich, St. Louis, MO) (Roberts et al., 2003). The eluted
fraction was dialyzed against 10 mM Tris, pH 7.6 and applied to a HPLC-DEAE anion
exchange column and eluted with a linear gradient of 0 to 0.3 M NaCl (Roberts et al.,
2003). The resulting purified bCBG was dialyzed against 10 mM Tris, pH of 7.6, and
cortisol was added for storage (Roberts et al., 2003). Location of bCBG in column
eluates was monitored by an optical density at 280 nm, SDS-PAGE, and 3H-cortisol
binding (Schiller and Pétra, 1976).
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To generate a population of polyclonal antibodies specific for bCBG, 600 ug of
purified bCBG obtained from the above procedures was sent to Pacific Immunology
Corp. (Ramona, CA). Two rabbits were immunized with 120 ug of bCBG and were
provided three subsequent boosters of 60 ug of bCBG that occurred 22, 43, and 71 d
after the first immunization. Rabbit anti-bCBG serum was harvested via exsanguination
and retained for the bCBG ELISA described below.
Bovine CBG assay development was performed by following the procedures of
Signorella and Hymer (1984) and Roberts et al. (2003). First, 96-well plates were
coated with purified bCBG (20 ng/100 uL/well) in coating buffer (20 mM Tris, 100 mM
NaCl, pH 8.4), sealed, and incubated overnight at 4° C (Roberts et al., 2003). A
separate set of 96-well plates were blocked with 200 uL glassware treatment solution
consisting of 0.1 % BSA and 1X PBS, pH 7.4, sealed, and incubated at 4 C overnight
(Roberts et al., 2003). Both coated and blocked plates were washed for 4 cycles with
300 uL of 1X TBS (150 mM NaCl, 20 mM Tris, 3.1 mM sodium azide, pH 7.4), tapped
dry, and stored at -20 ⁰C with desiccant (Roberts et al., 2003). In glass tubes, plasma
samples (40 uL) were combined with 160 uL diluent (10 % BSA, 10X PBS, and 10 %
Tween 20) and 200 uL rabbit anti-bCBG serum at a dilution of 1/80,000, vortexed, and
stored overnight at 4 C. Similarly, vaginal flush samples (25 uL) were combined with
175 uL diluent and 200 uL rabbit anti-bCBG serum at a dilution of 1/80,000, vortexed,
and stored overnight at 4 C. For each plate, standards ranging from 0.3 to 160 ng/100
uL/well were prepared and combined with rabbit anti-bCBG at a dilution of 1/80,000 and
stored overnight at 4 C. Tubes containing either standard-rabbit anti-bCBG or sample40

rabbit anti-bCBG mixtures were vortexed and 120 uL of the mixture was transferred to a
blocked plate, sealed, and allowed to incubate overnight at 4 C. An aliquot of 100 uL
from each well of blocked plate well was transferred to the corresponding well on a
bCBG coated well and incubated at 37 C for 2 hr in a humid chamber. Following the
incubation period, the bCBG coated plates containing sample-rabbit anti-bCBG mixtures
were washed for 4 cycles with 300 uL of tris buffered saline with Tween-20 (TBST; 150
mM NaCl, 0.05 % Tween 20, 20 mM Tris, 3.81 mM sodium azide, pH 7.4) and tapped
dry (Roberts et al., 2003). Then, 100 uL of a 1/16,000 dilution solution of goat antirabbit IgG conjugate to alkaline phosphatase (A3687; Sigma-Adrich) was added to each
well and allowed to incubate at 37° C for 2 hr in a humid chamber. Plates were washed
again for 4 cycles with TBST, tapped dry, and 100 uL of phosphatase substrate, paranitro-phenyl-phosphate in diethanolamine buffer (SeraCare Life Sciences, Inc., Milford,
MA), was added to each well followed by an incubation period of 1.5 hr at 37° C in a
humid chamber (Roberts et al., 2003). Following incubation, 100 uL of stop solution
(0.05 % Na2EDTA) was added to each well and absorbance was read at a 405 nm
wavelength by an ELX808 (BioTek Instruments, Inc., Winooski, VT). Data were
quantified using Gen5 software version 2.03 (BioTek Instruments, Inc., Winooski, VT).
For plasma samples, intra- and inter-assay CV were 13.0 % and 20.0 % for internal
control A (3.78 mg/L), and 6.5 % and 24.3 % for internal control B (4.62 mg/L). For
vaginal flush samples, intra- and inter-assay CV were 15.5 % and 19.2 % for internal
control A (2.02 mg/L), and 15.8 % and 18.7 % for internal control B (3.14 mg/L).
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Free hormone index
Progesterone and cortisol concentrations were converted from ng/mL to nmol/L
by a multiplicative conversion factor of 3.18 and 2.76, respectively (Graham et al.,
2011). Steroid hormone concentration (nmol/L) was then divided by CBG concentration
(mg/L) to calculate a free hormone index (nmol/mg) for both progesterone (FPI) and
cortisol (FCI) (Le Roux et al., 2003).
Statistical analysis
All heifers enrolled in the study (n = 67) were used to examine the relationship
between the steroid hormones and CBG profiles and the ability to conceive following
synchronization of ovulation and AI. In addition, all heifers that were confirmed
pregnant following timed AI (n = 24) were used as a sub-population to examine the
influence of progesterone during synchronization of ovulation and early gestation on
circulating and vaginal concentrations of cortisol, progesterone, and CBG.
All statistical analyses were performed in SAS 9.3 (SAS Institute, Cary, NC,
USA). A mixed model analysis of variance with heifer as the experimental unit was
performed to assess the effect of synchronization of ovulation and early gestation on
measured dependent variables. Sampling day was used in the model as a repeated
measure, and pen and heifer were included as random blocking effects. Fisher’s LSD
test was used to separate means (P ≤ 0.05).
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Results
Systemic endocrine response to synchronization of ovulation and pregnancy
All tables and figures are included in the appendix at the end of this chapter.
Plasma progesterone, cortisol, and CBG concentrations measured prior to CIDR
insertion and immediately following CIDR removal were similar (P > 0.10) among heifers
that became pregnant following AI and those that remained open (Table 3). Likewise,
plasma FPI and FCI calculated from progesterone, cortisol, and CBG concentrations
measured prior to and immediately following CIDR insertion and removal were not
different (P > 0.40) among heifers that became pregnant following AI and those that
remained open (Table 3). However, plasma samples collected at pregnancy diagnosis
on d 38 from heifers with successful pregnancies following synchronization and AI had
significantly greater (P = 0.02) concentrations of progesterone than samples collected
on d -7 (Figure 1A), but were not different than those measured on d 0. Similarly,
plasma CBG concentrations measured on d -7 and 0 did not differ, but were greatest (P
= 0.03) on d 38 at pregnancy diagnosis (Figure 1B). The FPI calculated from
progesterone and CBG concentrations measured on the three sampling days were not
different (P = 0.16; Figure 1C). Similar to plasma progesterone concentrations,
circulating concentrations of cortisol were consistent during synchronization of ovulation
(d -7 and 0), but were lower (P = 0.01) at pregnancy diagnosis (d 38; Figure 1D).
Likewise, FCI did not change during synchronization of ovulation, but was lowest (P <
0.0001) at pregnancy diagnosis on d 38 (Figure 1E).
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Vaginal polymorphonuclear neutrophil (PMN) percentage
The insertion of a CIDR for a period of 7 d resulted in an increase (P < 0.0001) of
approximately 42 % in the percentage of PMN within the vaginal cavity. At the time of
CIDR insertion (d -7), PMN accounted for 7.28 ± 2.83 % of the total cells on the
cytological slides whereas PMN accounted for 48.85 ± 2.81 % of the total cells when the
CIDR was removed (d 0). Although day differences existed, no differences in PMN
were observed between heifers that became pregnant or remained open following
synchronization of ovulation and artificial insemination (Table 4).
Vaginal steroid hormone profiles in response to synchronization of ovulation
Vaginal flush progesterone, cortisol, and CBG concentrations measured prior to
CIDR insertion and immediately following CIDR removal were not different (P > 0.30)
among heifers that became pregnant following AI and those that remained open (Table
4). Likewise, vaginal flush FPI and FCI calculated from progesterone, cortisol, and CBG
concentrations measured in the recovered flush solution prior to and immediately
following CIDR insertion and removal were not different (P > 0.70) among heifers that
became pregnant following AI and those that remained open (Table 4). However,
among heifers that became pregnant following AI, progesterone concentrations
contained within vaginal flush samples collected immediately after CIDR removal on d 0
were approximately four times greater (P < 0.0001) than concentrations measured
immediately prior to CIDR insertion on d -7 (Figure 2A). Although there was a rise in
progesterone concentration within vaginal flush samples as a result of CIDR insertion,
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CBG concentrations measured on d -7 were not different (P = 0.21) from those
measured on d 0, and thus, the FPI on d 0 was greater (P < 0.0001) than on d -7
(Figure 2B and C). Vaginal cortisol concentrations measured immediately following
CIDR removal were approximately two times greater (P < 0.0001) than those measured
before the CIDR was inserted (Figure 2D). Similarly, vaginal FCI was greater (P <
0.0001) at CIDR removal than at CIDR insertion (Figure 2E).
Discussion
In the present study, the pregnancy rate of heifers synchronized following the 7 d
CO-Synch + CIDR protocol and TAI was 35.8 %. The overall low pregnancy rate
observed in our study in comparison to a typical pregnancy rate of 53 % in heifers
undergoing TAI may be a result of the synchronization protocol used or the imposed
research sample collection methods (Hall et al., 2005). In previous years at the
University of Tennessee Beef Heifer Development Program, synchronization of
ovulation was performed using the 14-d CIDR-PG protocol, but heifers in our study
underwent the 7 d CO-Synch + CIDR protocol. In pre-pubertal heifers, CIDRs are used
to induce cyclicity among a cohort of individuals at various stages of pubertal
development (Rhodes, 1998; Lucy et al., 2001; Kesler, 2002). During the CIDR
insertion period, the low dose release of progesterone prevents follicular wave turn-over
and promotes the development of a persistent dominant follicle by increasing luteinizing
hormone (LH) pulse frequency (Savio et al., 1993; Kojima et al., 2003). As the
persistent follicle continues to develop, estradiol production and release subsequently
increases (Kojima et al., 2003). Through positive feedback on the hypothalamus,
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estradiol promotes the release of GnRH and subsequent LH production and release
from the anterior pituitary gland (Kesner et al., 1981), and in pre-pubertal heifers this
mechanism allows for the initiation of cyclicity (Anderson et al., 1996; Imwalle et al.,
1998). Therefore, the reduction in pregnancy rates observed in our heifers may be a
refection in the inability of some heifers to achieve cyclicity or synchrony at the time of
synchronization and breeding (Busch et al., 2007). However, we cannot be certain
because estrus detection patches or observation of standing heat were not components
of this study.
In addition to the synchronization protocol used, we cannot rule out the possibility
that the method used to collect vaginal flush samples did not affect pregnancy success
in the heifers. Vaginal flush collections are a common method to assess reproductive
status in other species (Caligioni, 2009), and to our knowledge, no adverse effects
following sample collection have been reported. However, although we used sterile
biological saline to infuse into the vaginal cavity and collection was performed in an
aseptic manner, it is possible that the collection method may have had an adverse
effect on the ability of heifers to become pregnant following the synchronization period.
Thus, precaution is advised to ensure external contaminants are not introduced into the
reproductive tract and all infused saline is recovered to minimize the impact of the
collection method on the reproductive tract.
In the present study, CIDR insertion did not significantly alter circulating
concentrations of progesterone, cortisol, or CBG. Recognizing that FPI and FCI are
directly proportional to progesterone, cortisol, and CBG concentration, it is not
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surprising that FPI and FCI were not affected by the insertion period. However, the
numeric rise in circulating progesterone concentration at the time of CIDR removal
indicates that the CIDRs increased plasma progesterone concentrations and were
consistent with concentrations previously reported for beef cattle (Kesler, 2002). At the
time of CIDR insertion, mean progesterone concentrations were 7.15 nmol/L (2.25
ng/mL) for heifers that failed to conceive following TAI, and 8.15 nmol/L (2.56 ng/mL) for
those that became pregnant. Considering heifers were not pre-synchronized and were
at various stages of the estrous cycle at the time of CIDR insertion, we cannot rule out
the possibility that some heifers had not achieved puberty by the time the study started.
Puberty in beef cattle can be assessed by collecting consecutive weekly samples in
which circulating progesterone concentrations exceed 1 ng/mL in two of the three
samples collected. In the current study, 13 heifers had plasma progesterone
concentrations less than 1 ng/mL at the start of our study, but because only one blood
sample was taken before the CIDR was inserted, we cannot conclude if the low
progesterone concentrations observed in those 13 heifers was a result of anestrus or
the stage of the estrous cycle in which the samples were collected.
Although CIDR insertion did not appear to affect plasma concentrations of CBG,
CBG was greatest at the time of pregnancy diagnosis on d 38 among heifers that
became pregnant following TAI. During this time, plasma progesterone concentrations
were also greater than those measured during the synchronization period. Although
CBG concentrations have not been examined in regards to progesterone and
pregnancy in bovine, the response observed in the present study is consistent with
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those reported for human pregnancy. Rosenthal et al. (1969) conducted a study to
observe the free and bound fractions of progesterone during the trimesters of human
pregnancy, and it was postulated that CBG acts a buffer to limit the amount of free
progesterone throughout the course of pregnancy. The authors observed an increase
in CBG-bound progesterone from 37 to 43 %, whereas free progesterone was
maintained at approximately 2 % throughout pregnancy, and the rise in CBG-bound
progesterone was concurrent with the overall rise in circulating progesterone
concentrations throughout the three trimesters (Rosenthal et al., 1969). Additionally, by
the second trimester CBG became the primary transporter for progesterone (Rosenthal
et al., 1969), and is believed to function as a buffer to regulate the amount of free
progesterone in circulation, extend the half-life, and to create a reserve of the steroid
(Siiteri et al., 1982; Bright, 1995; Klieber et al., 2007). Plasma progesterone
concentrations measured here in pregnant heifers at the time of pregnancy diagnosis
were greater than those measured during synchronization, and were concurrent with the
rise in plasma CBG levels observed on d 38. Also in agreement with Rosenthal et al.
(1969), we found no differences in the amount of free progesterone in circulation at the
time of pregnancy diagnosis. This response suggests that similar to humans, CBG may
act to regulate the proportion of free progesterone in circulation especially during
periods of high progesterone influence such as pregnancy. However, we must also
consider the relationship between CBG and cortisol, another steroid in which it binds
with a high affinity (Klieber et al., 2007).
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During periods of stress or during the inflammatory response, CBG acts as a
negative acute phase protein as shown by a reduction in circulating CBG concentrations
(Pugeat et al., 1989; Tsigos et al., 1998). During the inflammatory response, there is an
increase in neutrophils which release neutrophil elastase that can cleave the RCL of
CBG (Hammond et al., 1990). Once the RCL has been cleaved, CBG can no longer
bind the steroid in which it was transporting, thus allowing the steroid to be in its
biologically available state (Simard et al., 2014; Lewis and Elder, 2017). Therefore,
when cortisol concentrations are elevated, a reduction in circulating CBG concentration
occurs to allow for an increase in bioavailable cortisol. At the time of pregnancy
diagnosis in pregnant heifers in the present study, plasma cortisol concentrations were
lowest during the time in which CBG concentrations were the highest. Although this
response is consistent with CBG’s role as a negative acute phase protein, plasma
cortisol concentrations on d 38 were 21.0 nmol/L (7.62 ng/mL) lower than those
measured on d 0 and were less than baseline cortisol concentrations previously
reported in beef heifers (Edwards et al., 1987). Therefore, we speculate that the
increase in CBG concentrations during early gestation was not a result of reduced
cortisol concentration, but a reflection in the sustained increase in progesterone
concentration that occurs with pregnancy. However, to support the previous statement,
a subsequent study would have to be performed in which multiple blood samples were
collected throughout early gestation to examine the fluctuations in plasma progesterone,
cortisol, and CBG concentration, and to evaluate the binding distribution of CBG.
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Although CIDR insertion did not appear to influence the systemic endocrine
response in heifers undergoing synchronization of ovulation, CIDRs directly altered the
local vaginal endocrine response, but these changes were not related to the ability of
the heifers to conceive following TAI. Additionally, CIDRs induced a localized
inflammatory response within the vaginal cavity as indicated by a 42 % increase in PMN
migration within the vaginal lumen at the time of CIDR removal which is consistent with
other studies conducted that have reported an increased infiltration of neutrophils within
the reproductive tract of cattle undergoing synchronization (Ahmadi et al., 2007; Çevik
et al., 2010; Fischer-Tenhagen et al., 2012). We did not examine the percentage of
neutrophils in circulation, but because plasma cortisol concentration did not differ
between d -7 and 0, it does not appear that CIDR insertion induced a systemic
inflammatory response which would be represented by a rise in cortisol concentration
(Chrousos, 1995; Steensberg et al., 2003).
CIDR insertion resulted in an increase in progesterone concentration measured
within the vaginal lumen, but did not alter the amount of CBG within the vagina.
Therefore, there was also a rise in the amount of free progesterone within the vaginal
cavity. These data are not surprising because we know that the mechanism as to which
CIDRs work to synchronize cattle relies on the absorption of exogenous progesterone
through the vaginal epithelium to cause a rise in systemic progesterone concentrations.
Surprisingly, vaginal cortisol concentrations also increased during the CIDR insertion
period, but because cortisol acts as a regulatory agent during the inflammatory
response (Hammond et al., 1990), we believe this response occurred as a result of
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neutrophil migration that occurred during CIDR insertion. The presence of a CIDR has
been linked to a numeric increase in the proportion of neutrophils within the vaginal
cavity and an overall reduction in circulating neutrophils (Ahmadi et al., 2007; Walsh et
al., 2008). These patterns were noted for both progesterone impregnated and nonimpregnated devices and thus, the response appears to be a result of the presence of
the device within the vaginal cavity (Ahmadi et al., 2007; Walsh et al., 2008). In addition
to mechanical induction of the immune response, hormones have the capability to
impact the activity and presence of neutrophils within an individual. Specifically, Lasarte
et al. (2016) reported that progesterone administration induced a Cxcl1 chemokine
gradient that promoted neutrophil infiltration into the vaginal cavity of mice. Others have
reported that progesterone can also impact the survivability of immune cells, such that
neutrophil apoptosis was reduced in vitro when the immune cells were subjected to
progesterone, and neutrophils harvested from women showed a greater reduction in
apoptosis when compared to those harvested from men (Molloy et al., 2003). Thus, it
appears that CIDRs impregnated with progesterone have the potential to impose a
multifaceted effect on the local immune response within the vagina.
We did not evaluate the cortisol and progesterone binding properties of bovine
CBG as part of this study. In regards to human CBG, the glycoprotein binds cortisol
with a higher affinity than progesterone, but both with a much higher affinity than that of
albumin (Mickelson et al., 1981; Hammond, 2016). We were able to detect fluctuations
in the amount of CBG measured within plasma as a result of early gestation in cattle
that we believe is a reflection of heightened progesterone influence. Future work should
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be aimed at evaluating the binding affinity of CBG for both progesterone and cortisol via
Scatchard analysis to determine if bovine CBG binding affinities are similar to those
reported for human CBG.
Conclusion
To the best of our knowledge, this study is the first to examine the effect of
exogenous progesterone release from a CIDR on local and systemic concentration of
CBG and the corresponding FPI and FCI in heifers undergoing synchronization of
ovulation. Progesterone release from a CIDR inserted for a 7 d period as part of the 7 d
CO-Synch + CIDR protocol did not affect systemic or vaginal concentrations of CBG in
heifers enrolled in the current study. Likewise, the endocrine profiles measured did not
affect the ability of the heifers to become pregnant following synchronization and TAI.
At the time of the CIDR insertion on d -7, heifers were at various stages of the estrous
cycle. To determine if in fact CIDR insertion does not alter circulating concentrations of
CBG during the 7 d period, a subsequent study should be conducted such that heifers
are pre-synchronized and are at the same stage of the estrous cycle at the time of the
CIDR insertion. In regards to early pregnancy, it appeared that CBG concentrations
increased in response to the heightened output of progesterone resulting in stabilization
of the amount of free progesterone in circulation. Altogether, based on the preliminary
data reported in this study, there is evidence to suggest that bovine CBG functions in a
similar manner to human CBG during early gestation.
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Appendix
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Table 1. Validation of MP Biomedicals Progesterone Double Antibody RIA kit for
determination of progesterone concentration within vaginal flush samples collected on d
0 and 7 of synchronization of ovulation.
Heifer1
A

B

C

D

undiluted

[P4]
(ng/mL)
4.52

Corrected [P4]
(ng/mL)
-

undiluted

113.32

-

300 uL sample : 100 uL saline

69.03

91.81

200 uL sample : 200 uL saline

48.00

96.00

100 uL sample : 300 uL saline

21.44

85.77

-7

undiluted

10.83

-

0

undiluted

38.38

-

300 uL sample : 100 uL saline

33.20

44.15

200 uL sample : 200 uL saline

25.04

50.07

100 uL sample : 300 uL saline

11.31

45.24

-7

undiluted

6.27

-

0

undiluted

99.49

-

300 uL sample : 100 uL saline

74.75

99.42

200 uL sample : 200 uL saline

51.32

102.64

100 uL sample : 300 uL saline

26.26

105.02

-7

undiluted

BDL2

-

0

undiluted

60.74

-

300 uL sample : 100 uL saline

45.48

60.49

200 uL sample : 200 uL saline

29.86

59.72

100 uL sample : 300 uL saline

14.22

56.87

Day
-7
0

Dilution

1

Four heifers were selected at random for the validation.
Below detectable limits (BDL).

2
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Table 2. Validation of vaginal flush cortisol concentrations (ng per volume concentrated)
obtained following Sep-Pak Classic C18 Cartridge extraction and Salimetrics High
Sensitivity Salivary Cortisol EIA quantification.
2

Sample preparation
1 mL concentrated
2 mL concentrated
5 mL concentrated
10 mL concentrated

Day of vaginal flush collection1
Pre-CIDR (d -7)
Post-CIDR (d 0)
0.02
0.19
0.02
0.24
0.11
0.42
0.61
1.81

1

Vaginal flush samples were collected immediately prior to CIDR insertion on d -7 and
immediately following CIDR removal on d 0.
2
Samples (pre-CIDR and post-CIDR) from one heifer were chosen at random for this
validation. Sample aliquots at varying volumes (1, 2, 5, and 10 mL) were concentrated
using the Sep-Pak C18 cartridges and reconstituted in 100 uL of 0.9 % sodium chloride
sterile saline. Concentrations are represented as total ng of cortisol contained within
each volume (1, 2, 5, and 10 mL) concentrated.
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Table 3. Comparison of measured plasma variables (mean ± SEM) on d -7 and 0
between heifers that became pregnant (n = 24) following synchronization of ovulation
followed by artificial insemination and those that remained open (n = 43).
Pregnancy status on d 38
Day
P-Value
Plasma variable
Open
Pregnant
-7
Progesterone (nmol/L)
7.15 ± 1.52
8.15 ± 2.03
0.15
0
11.46 ± 1.94
10.69 ± 2.28
-7
Cortisol (nmol/L)
54.06 ± 5.25
51.58 ± 7.08
0.55
0
76.89 ± 5.28
61.39 ± 7.02
-7
CBG (mg/L)
4.11 ± 0.31
5.22 ± 0.52
0.15
0
4.37 ± 0.33
4.58 ± 0.46
-7
FPI2 (nmol/mg)
1.68 ± 0.27
1.55 ± 0.36
0.43
0
2.42 ± 0.34
2.25 ± 0.42
-7
FCI2 (nmol/mg)
9.75 ± 1.61
7.91 ± 1.77
0.47
0
14.42 ± 2.42
11.42 ± 2.52
1
Plasma samples were collected from each heifer prior to CIDR insertion on d -7 and
immediately following CIDR removal on d 0.
2
Steroid hormone concentration (nmol/L) was then divided by CBG concentration (mg/L)
to calculate a free hormone index (nmol/mg) for both progesterone (FPI) and cortisol
(FCI).
1
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Table 4. Comparison of variables measured in flush vaginal flush samples (mean ±
SEM) on d -7 and 0 between heifers that became pregnant (n = 24) following
synchronization of ovulation followed by artificial insemination and those that remained
open (n = 43).
1

Vaginal variable
Progesterone (nmol/L)
Cortisol (nmol/L)
CBG (mg/L)
FPI2 (nmol/mg)
FCI2 (nmol/mg)
PMN3 (%)

Day
-7
0
-7
0
-7
0
-7
0
-7
0
-7
0

Pregnancy status on d 38
Open
Pregnant
33.63 ± 15.62
34.08 ± 17.18
139.87 ± 31.75
136.34 ± 34.69
0.038 ± 0.006
0.038 ± 0.006
0.078 ± 0.012
0.073 ± 0.013
2.60 ± 0.18
2.32 ± 0.21
2.66 ± 0.18
2.66 ± 0.21
14.38 ± 7.84
14.92 ± 8.54
52.73 ±15.04
52.92 ± 16.20
0.016 ± 0.003
0.018 ± 0.004
0.030 ± 0.007
0.029 ± 0.007
7.81 ± 3.22
6.75 ± 3.87
47.98 ± 3.20
49.72 ± 3.81

1

P-Value
0.95
0.66
0.35
0.95
0.75
0.92

Vaginal flush samples were collected from each heifer by infusing 60 mL of sterile
saline into the vaginal cavity prior to CIDR insertion on d -7 and immediately following
CIDR removal on d 0. Concentrations are represented as whole concentrations
contained within the flush sample.
2
Steroid hormone concentration (nmol/L) was then divided by CBG concentration
(mg/L) to calculate a free hormone index (nmol/mg) for both progesterone (FPI) and
cortisol (FCI).
3
Polymorphonuclear neutrophils (PMN) within the vaginal cavity were assessed prior to
CIDR insertion on d -7 and immediately following CIDR removal on d 0.
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Figure 1. Mean ± SEM plasma constituents measured during synchronization of
ovulation and early gestation in heifers that became pregnant following synchronization
and AI (n = 24). Progesterone impregnated CIDRs were inserted on d -7 and removed
on d 0. Pregnancy diagnosis via transrectal ultrasonography occurred on d 38. Steroid
hormone concentration (nmol/L) was divided by CBG concentration (mg/L) to calculate
a free hormone index (nmol/mg) for progesterone (FPI; Figure 1C) and cortisol (FCI;
Figure 1E). a,bMeans with different superscripts differ.
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Figure 2. Mean ± SEM progesterone, CBG, cortisol, FPI, and FCI measured in vaginal
flush samples collected during synchronization of ovulation in heifers that became
pregnant following synchronization and AI (n = 24). Progesterone impregnated CIDRs
were inserted on d -7 and removed on d 0. Steroid hormone concentration (nmol/L)
was divided by CBG concentration (mg/L) to calculate a free hormone index (nmol/mg)
for progesterone (FPI; Figure 2C) and cortisol (FCI; Figure 2E). a,bMeans with different
superscripts differ.
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Chapter III
Presence of Pseudomonas aeruginosa within the vaginal cavity of
heifers undergoing synchronization of ovulation and the influence on
biologically available steroid hormones
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Abstract
Pseudomonas aeruginosa is a gram negative aerobic bacteria that is commonly
found in the environment and is capable of colonizing the vaginal cavity of a variety of
species. The presence of Pseudomonas aeruginosa within the bovine vaginal cavity
has not been well characterized, but there is evidence to suggest that the presence of a
controlled internal drug release device (CIDR) can alter the abundance of the bacteria
inhabiting the cavity. Pseudomonas aeruginosa produces and releases LasB, a
protease that is capable of cleaving the reactive center loop (RCL) of corticosteroidbinding globulin (CBG), a transporter for cortisol and progesterone. When cleavage
occurs, the steroid dissociates from CBG and is considered biologically available. The
main objective of the present study was to examine the effect of exogenous
progesterone released from a CIDR on the presence of Pseudomonas aeruginosa
within the vaginal cavity of heifers undergoing synchronization of ovulation using the 7 d
CO-Synch + CIDR protocol. Additionally, we examined the relationship between
Pseudomonas aeruginosa and CBG concentration in the vaginal cavity as it relates to
the biologically available fractions of progesterone and cortisol. Beef heifers (n = 67)
were enrolled in the study and immediately prior to CIDR insertion on d -7, and
immediately following CIDR removal on d 0, vaginal flush samples were collected. The
abundance of Pseudomonas aeruginosa was quantified using quantitative PCR.
Steroid concentrations were determined using a commercially available RIA and CBG
was quantified by an in-house ELISA. Steroid hormone concentration (nmol/L) was
then divided by CBG concentration (mg/L) to calculate a free hormone index (nmol/mg)
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for both progesterone (FPI) and cortisol (FCI). A mixed model ANOVA with repeated
measures was performed, and Spearman correlations were used to examine the
relationship between the presence of Pseudomonas aeruginosa and the endocrine
variables measured. During the 7 d CIDR insertion period, the abundance of
Pseudomonas aeruginosa within the vaginal flush samples decreased (P < 0.0001), but
presence of Pseudomonas aeruginosa within the vaginal cavity was not related (P =
0.96) to pregnancy status following synchronization of ovulation and AI. Pseudomonas
aeruginosa was unrelated (P > 0.10) to progesterone concentration, cortisol
concentration, and the FPI measured within the vaginal flush samples. In contrast,
Pseudomonas aeruginosa abundance at the time of CIDR insertion on d -7 was
negatively related (r = -0.32; P = 0.04) to the percentage of PMN within the vaginal
cavity, but no relationship (P = 0.68) between the two variables was observed on d 0
when CIDRs were removed. On d 0, Pseudomonas aeruginosa abundance was related
to both CBG concentration (r = -0.25; P = 0.05) and FCI (r = 0.37; P = 0.004). In
summary, the presence of Pseudomonas aeruginosa decreased as a result of CIDR
insertion, but was unrelated to vaginal progesterone concentration. However, under the
current methods, it appears that Pseudomonas aeruginosa within the vaginal cavity of
heifers may have to potential to alter the free proportion of cortisol as seen by a
reduction in CBG concentration.
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Introduction
Within the last few years, researchers have started to examine the interactions
between hormone production and bacterial community profiles that exist within the
bovine vagina, and it has been reported that changes in the diversity and abundance of
bacteria occur as hormone profiles vary (Laguardia-Nascimento et al., 2015).
Furthermore, during pregnancy, a physiological state characterized by heightened
progesterone production, the bovine vaginal microbiome undergoes a reduction in both
bacterial diversity and abundance of bacteria inhabiting the cavity (Walther-António et
al., 2014; Laguardia-Nascimento et al., 2015). Although research has aimed to
characterize the existing bacterial community profiles in the bovine vaginal cavity, the
direct effect of exogenous progesterone release from a controlled internal drug release
device (CIDR) on the population of local bacterial communities in cattle undergoing
estrous synchronization remains unclear.
In women, Pseudomonas aeruginosa is an aerobic opportunistic bacterial
pathogen that can colonize the vaginal epithelium and lead to infection (Osset et al.,
2001; Hammond, 2016). Studies that have characterized the bovine vaginal bacterial
community profiles reported that Pseudomonadaceae are present within the vaginal
cavity (Laguardia-Nascimento et al., 2015), but the prevalence of P. aeruginosa is not
well documented in cattle. Previously, Padula and Macmillan (2006) examined the
effect of CIDR (1.9 g progesterone) insertion on cultured bacterial isolates found within
the vagina of postpartum Holstein cows. The study was designed such that three
treatments were administered (control: no CIDR; CIDR-P4: two intravaginal devices
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containing progesterone were administered for 14 d; CIDR-Blank: two intravaginal
devices without progesterone were administered for 14 d) and vaginal swabs were
performed on d 0 (day of CIDR insertion), 7, and 14 to examine culturable bacterial
profiles (Padula and Macmillan, 2006). They reported that the number of samples
positive for P. aeruginosa increased over the sampling period in cows that received a
CIDR. Likewise, the presence of P. aeruginosa was greater in the CIDR-P4 treated
cows when compared to the other two treatment groups (Padula and Macmillan, 2006).
Thus, it appears that the presence of the CIDR and progesterone are capable of altering
the abundance of P. aeruginosa within in the bovine vaginal cavity.
P. aeruginosa has the capability to synthesize and release LasB (P. aeruginosa
elastase), a protease that can cleave the reactive center loop (RCL) of the steroid
hormone transporter, corticosteroid-binding globulin (CBG) (Simard et al., 2014;
Hammond, 2016). When Simard et al. (2014) incubated human CBG in a culture of P.
aeruginosa, they observed a 90 % reduction in the cortisol-binding capacity of CBG and
a 5-10 kDa loss. Furthermore, when human CBG was incubated with protease fractions
extracted from P. aeruginosa, only LasB reduced the cortisol-binding capacity of CBG
and proved to have the ability to interfere with the ability of CBG to bind steroids within
the RCL (Simard et al., 2014). Based on the study performed by Simard et al. (2014)
and the presence of P. aeruginosa in the bovine vaginal cavity as reported by Padula
and Macmillan (2006), further investigation is warranted to determine if this particular
bacteria has the ability to influence CBG and free progesterone concentrations during
the estrous synchronization process.
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The objective of the present study was to examine the effect of exogenous
progesterone released from a CIDR on the presence of P. aeruginosa within the vaginal
cavity of heifers undergoing synchronization of ovulation using the 7 d CO-Synch +
CIDR protocol. Additionally, we aimed to examine the relationships between P.
aeruginosa and CBG concentration in the vaginal cavity as it relates to the free fractions
of progesterone and cortisol. Based on the literature presented above, we
hypothesized that CIDR insertion would increase the abundance of P. aeruginosa within
the vaginal lumen, and that heifers with a greater abundance of P. aeruginosa would
have lower CBG concentrations and greater proportion of free steroid within the vaginal
lumen.
Materials and Methods
Animals
Prior to animal manipulation, procedures were approved by the University of
Tennessee Institutional Animal Care and Use Committee. Heifers (n = 67) enrolled in
the study were consigned to the University of Tennessee Beef Heifer Development
Program in Lewisburg, TN on October 3, 2016 and remained in the program until
September, 2017. At arrival, heifer age and body weight ranged from 182 to 383 d of
age and 198.67 to 390.09 kg, respectively. Breed composition included the following:
Angus (n = 28), Angus x Hereford (n = 4), Angus x Shorthorn (n = 2), Angus-cross (n =
9), Charolais (n = 7), Gelbvieh (n = 4), Hereford (n = 4), Simangus (n = 4), and
Simmental (n = 5). All heifers were housed on pasture and received the same feed
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ration over the course of the program. Ad libitum access to water and supplemented
hay was also provided.
Tissue collection and synchronization of ovulation
Synchronization of ovulating began on March 2017 when heifers were 416 ±
33.73 d of age and had an average body weight of 415 ± 36 kg. On d -7, immediately
prior to the administration of GnRH (100 ug, Factrel; Zoetis, Madison, NJ) and CIDR
(1.38 g progesterone; Eazi-Breed CIDR, Zoetis, Madison, NJ) insertion as part of the 7
d CO-Synch + CIDR protocol, blood (6 mL) was collected in sodium heparin vacutainer
tubes (Becton Dickinson, Franklin Lakes, NJ) via coccygeal venipuncture. Blood
samples were centrifuged (Sero-Fuge Centrifuge, Clay Adams, Inc., Parsippany, NJ) for
10 min and plasma was harvested, aliquoted into three 2 mL microcentrifuge tubes,
then stored at -20°C until later cortisol, progesterone, and CBG analyses. Following
blood collection, the vulva was cleaned with 70 % ethanol, and vaginal cytological
samples were collected by inserting a cytobrush (Cooper Surgical, Inc., Trumbull, CT)
into the vaginal lumen and rotating the brush clockwise against the vaginal epithelium
(Stratman et al., 2016). Cytobrushes were rolled onto microscope slides and slides
were allowed to air dry prior to being stained with a modified Wright-Giemsa stain
(Protocol hema 3 stain set, Fisher Scientific Co, Pittsburgh, PA) (Stratman et al., 2016).
Under 100X magnification, approximately 200 cells were counted to determine the
proportion of polymorphonuclear neutrophils (PMN) to total cells present on the slide
(Ghasemi et al., 2012; Stratman et al., 2016). Vaginal flushes were then performed by
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inserting a rubber catheter attached to a 60 mL syringe into the vagina and 60 mL of 0.9
% sodium chloride sterile saline was infused into the vagina and recovered via vaginal
lavage and caught in a plastic cup, then transferred to a 50 mL conical tube. Following
collection, vaginal flush samples were centrifuged at 2,000 rpm (821 x g; Beckman
Coulter Allegra X-14R Centrifuge, Brea, CA) for 5 min at 4°C, aliquoted into three 13 mL
culture tubes, and stored at -20°C until later cortisol, progesterone, and CBG
determination.
The same procedures mentioned above to collect blood and vaginal flush
samples were performed again on d 0 when CIDRs were removed and PGF2α was
administered. On d 2, heifers received another injection of GnRH immediately prior to
AI.
Pseudomonas aeruginosa quantification within vaginal swabs
P. aeruginosa ATCC 27853 was grown overnight in 5 mL of Tryptic Soy Broth
(Becton, Dickinson, and Company, Sparks, MD) with shaking at 37⁰ C. Serial dilutions
were performed to obtain sub-samples ranging from 10-1 to 10-9. Then, 100 uL from 103

to 10-7 samples were plated in triplicate on Luria-Bertani agar plates (Becton,

Dickinson, and Company, Sparks, MD), incubated overnight at 37⁰ C, and colony
forming units (CFU) were counted on each plate. Following DNA isolation procedures
described above, DNA was extracted from 1 mL of the sub-samples ranging from 100 to
10-9, and were used to generate a standard curve on each PCR 96-well plate that
ranged from 7.0 x 102 to 7.0 x 108 CFU·mL-1.
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Vaginal flush samples were thawed, vortexed, and centrifuged at 3,280 x g for 20
min, then the resulting supernatant was discarded and pellets were re-suspended in
180 uL of Bufffer ATL provided within the DNeasy Blood & Tissue Kit (Qiagen, Hilden,
Germany)(Clemmons et al., 2017). Subsequent bacterial DNA extraction was
performed as per the manufacturer instructions within the DNeasy Blood & Tissue Kit
protocol for gram negative bacteria (Clemmons et al., 2017). Following extraction, DNA
concentration within each sample was quantified using a NanoDrop 1000
Spectrophotometer (Thermo Fisher Scientific, Wilmington, DE) (Lee et al., 2011).
Forward (722F: 5’-GGCGTGGGTGTGGAAGTC-3’) and reverse (788R: 5’TGGTGAAGCAGAGCAGGTTCT-3’) primers were designed to target a gyrB gene
specific sequence of P. aeruginosa (Lavenir et al., 2007; Lee et al., 2011). Each PCR
reaction contained a total volume of 40 uL which consisted of 20 uL PowerUpTM
SYBRTM Green Master Mix (Applied Biosystems, Life Technologies, Carlsbad, CA) and
2 uL of each the forward and reverse primers (500 nM) (Lee et al., 2011). The
remaining 16 uL consisted of varying volumes of nuclease-free water and DNA template
to achieve a final mass of 150 ng of DNA template per PCR reaction. A negative
control was constructed following the PCR reaction recipe above, but 16 uL of
nuclease-free water was used in place of the of DNA template. Amplification of DNA
was performed in triplicate using the QuantStudioTM 3 Real-Time PCR System with the
following thermal cycling settings. A preliminary hold stage at 50⁰ C for 2 min followed
by 95⁰ C for 2 min was performed, and 40 cycles of denaturation at 95⁰ C for 15 sec,
annealing at 58.5⁰ C for 1 min, and extension at 72⁰ C for 1 min was performed.
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Plasma steroid hormone analyses
Total plasma cortisol and progesterone concentration (ng/mL) were determined
by following the procedures of commercially available radioimmunoassay kits (MP
Biomedicals, Solon, OH; cat # 07-221102 and 07-170102, respectively) with a
sensitivity of 5 ng/mL and 0.2 ng/mL, respectively (Hulbert et al., 2013; Pohler et al.,
2016). Cortisol standards ranged from 5 to 1,000 ng/mL with a cross-reactivity less
than 12.3 % for related endogenous steroids. Intra- and inter-assay coefficients of
variation (CV) were 17.3 % and 25.9 % for low (2.27 ng/mL) and, 12.2 % and 15.0 % for
high (16.2 ng/mL) cortisol controls. Progesterone standards ranged from 0.2 to 50
ng/mL with a cross-reactivity less than 5.4 % for related endogenous steroids. Intraand inter-assay coefficients of variation (CV) were 6.7 % and 6.0 % for low (0.89 ng/mL)
and, 11.3 % and 15.1 % for high (5.0 ng/mL) progesterone controls.
Vaginal flush steroid hormone analyses
Total progesterone and cortisol concentrations within the vaginal flush samples
were determined by following the same RIA procedures as described in Chapter II using
the MP Biomedical Progesterone Double Antibody RIA kit and Salimetrics High
Sensitivity Salivary Cortisol EIA. Intra- and inter-assay CV were 3.6 % and 3.3 % for
low (5.93 ng/mL) and, 3.4 % and 5.7 % for high (51.0 ng/mL) progesterone controls.
Cortisol EIA with intra- and inter-assay CV of 5.0 and 7.5 % for low (1.17 ng/mL) and
3.3 and 7.8 % for high (9.62 ng/mL) cortisol standards.
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CBG concentration determination
Concentrations of bovine CBG (mg/L) were quantified by an indirect competitive
ELISA developed in our laboratory as described in Chapter II (Roberts et al., 2003;
Kattesh et al., 2014). For plasma samples, intra- and inter-assay CV were 13.0 % and
20.0 % for internal control A (3.78 mg/L), and 6.5 % and 24.3 % for internal control B
(4.62 mg/L). For vaginal flush samples, intra- and inter-assay CV were 15.5 % and 19.2
% for internal control A (2.02 mg/L), and 15.8 % and 18.7 % for internal control B (3.14
mg/L).
Free hormone index
To calculate the free fraction of cortisol and progesterone, concentrations of
cortisol and progesterone were converted from ng/mL to nmol/L by a multiplicative
conversion factor of 2.76 and 3.18, respectively (Graham et al., 2011). Steroid hormone
concentration (nmol/L) was then divided by CBG concentration (mg/L) to calculate a
free hormone index (nmol/mg) for both cortisol (FCI) and progesterone (FPI) (Le Roux
et al., 2003).
Statistical analysis
All heifers enrolled in the study (n = 67) were used to examine the relationship
between the bacterial, steroid hormones, and CBG profiles following synchronization of
ovulation and AI. In addition, heifers that were confirmed pregnant following timed
artificial insemination (n = 24) were used as a sub-population to examine the influence
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of progesterone during synchronization of ovulation and early gestation on vaginal
bacterial presence and concentrations of cortisol, progesterone, and CBG.
All statistical analyses were performed in SAS 9.3 (SAS Institute, Cary, NC,
USA). A mixed model analysis of variance with heifer as the experimental unit was
performed to assess the effect of synchronization of ovulation on measured dependent
variables. Sampling day was used in the model as a repeated measure, and pen and
heifer were included as random blocking effects. Fisher’s LSD test was used to
separate means (P ≤ 0.05). Spearman correlations were also performed to examine
relationships between the abundance of P. aeruginosa and the measured endocrinerelated variables.
Results
All tables are included in the appendix at the end of this chapter. All vaginal flush
samples were positive for P. aeruginosa as detected by qPCR analysis. During the 7 d
CIDR insertion period of the 7 d CO-Synch + CIDR protocol, the abundance of P.
aeruginosa within the vaginal flush samples exhibited a 3.5-fold decrease (P < 0.0001)
from 9,818.10 ± 2,034.94 CFU·mL-1 on d -7 to 2,797.69 ± 527.62 CFU·mL-1 on d 0.
However, no differences (P = 0.96) in P. aeruginosa abundance were observed on d -7
and 0 among heifers that became pregnant (n = 24) and those that remained open (n =
43) following synchronization of ovulation and timed AI (Table 5).
Overall means for progesterone, cortisol, CBG, FPI, FCI, and PMN measured on
d -7 and 0 are reported in Table 6. Spearman correlations were performed to assess
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the relationship between P. aeruginosa abundance and the other dependent variables
measured in the vaginal flush samples obtained on d -7 and 0. P. aeruginosa was
unrelated (P > 0.10) to progesterone concentration, cortisol concentration, and the FPI
measured within the vaginal flush samples collected on d -7 and 0 (Table 7). In
contrast, P. aeruginosa abundance within the vaginal cavity on d -7 was inversely
related (P = 0.04) to the percentage of PMN within the vaginal cavity such that heifers
with a greater abundance of PMN had fewer P. aeruginosa inhabiting the vaginal cavity,
but no relationship (P = 0.68) between the two variables was observed on d 0 when
CIDRs were removed (Table 7). On d 0, P. aeruginosa abundance was negatively
related to both CBG concentration (P = 0.05) and FCI (P = 0.004) measured in the
vaginal flush such that heifers with a greater abundance of P. aeruginosa had lower
CBG concentrations, but a greater proportion of free cortisol within the vaginal cavity
(Table 7). Likewise, FCI was directly related (r = 0.30; P = 0.02) to the percentage of
PMN within the vaginal cavity on d 0, such that heifers with a greater proportion of PMN
had a higher FCI.
Discussion
In addition to vaginal flush samples, vaginal swab samples were collected on d -7
and 0 with the intent to determine P. aeruginosa presence using a cotton swab
technique instead of vaginal flush collection method. Recognizing that P. aeruginosa is
a gram negative bacteria that is capable of adhering to host cells (Woods et al., 1980;
Holden et al., 1999), we hypothesized that vaginal bacterial swabs would serve as a
72

better collection method than the vaginal flush method. Following DNA extraction, swab
samples contained an average of 38.7 ng/uL of purified DNA on d -7 and 53.1 ng/uL on
d 0, but the qPCR methods described above were unable to detect P. aeruginosa within
the swab samples. In contrast, vaginal flush samples contained an average of 17.3
ng/uL of purified DNA on d -7 and 88.0 ng/uL on d 0 and P. aeruginosa was detectable
in samples collected using the vaginal flush method. We suspect that the bacterial
swab collection method was not adequate for obtaining a sufficient representative
sample of bacteria within the vaginal cavity of heifers. It is also possible that the swab
method collected primarily host cells from the vaginal epithelial instead of bacterial cells
within the lumen. Instead, vaginal flush samples are capable of flushing the vaginal
lumen by making contact with a greater surface area, and may be a more
representative sample of the bacteria communities inhabiting the vaginal lumen (Ball et
al., 1988).
Heifers enrolled in our study displayed a 3.5 fold reduction in the abundance of
P. aeruginosa following the 7 d CIDR insertion period. However, this was contrary to
our hypothesis and data reported by Padula and Macmillan (2006) who observed an
increase in the abundance of P. aeruginosa within the vaginal cavity as a result of CIDR
insertion. Although both studies were conducted in beef heifers consisting of Bos taurus
lineage, the experiment performed by Padula and Macmillan (2006) was conducted in
the Southern region of Australia during autumn which is characterized by warmer
seasonal temperatures and more rainfall than the spring climate in which our
experiment occurred. P. aeruginosa is an opportunistic environmental pathogen (Stover
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et al., 2000), and within the United States, its prevalence is affected by season such
that P. aeruginosa-induced respiratory infections in humans are observed more
commonly during the summer and autumn months when compared to winter and spring
months (Psoter et al., 2013). Thus, it is possible that environmental conditions may
have contributed to the varying results in our study and those reported by (Padula and
Macmillan, 2006). Likewise, all cows in their study were within the luteal phase of the
estrous cycle at the time of CIDR insertion. Recognizing the impact of progesterone on
the vaginal microbiome (Walther-António et al., 2014; Laguardia-Nascimento et al.,
2015), and that heifers in our study were at different stages of the estrous cycle, it is
also possible that our results conflicted to those reported by Padula and Macmillan
(2006) due to both the physiological hormone state of the animals at CIDR insertion and
the type of CIDR used.
Additionally, Padula and Macmillan (2006) recognized the chance of sampling
contamination among the cows enrolled in their study (Padula and Macmillan, 2006).
Therefore, it is possible that their observed response was a result of cow to cow
contamination and not necessarily a direct effect of CIDR insertion. However, among
the current literature it appears that there are disagreements in regards to the effect of
progesterone on bacterial communities within the bovine reproductive tract such that
Laguardia-Nascimento et al. (2015) observed a reduction in both the diversity and
abundance of bacteria within the vaginal cavity during pregnancy, a state characterized
by sustained progesterone influence, which is consistent with our results.
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In the present study, CIDR were inserted and the plastic tail attached to the
device was left intact. Previous research conducted by Fischer-Tenhagen et al. (2012)
suggested that the presence of the plastic tail is capable of altering the bacterial
communities within the vagina and reported an increase in the occurrence of purulent
discharge which was also observed in our samples. More specifically, the authors
noted an increase Escherichia coli, a pathogenic bacteria, within the vagina of heifers
who received a CIDR with intact tail (Fischer-Tenhagen et al., 2012). They also
reported that heifers who received CIDRs with intact tails were more likely to have their
CIDRs removed by pen-mates before the end of the synchronization period (FischerTenhagen et al., 2012). Taken together, it appears that CIDR insertion may provide a
route for pathogenic bacteria to enter the vaginal cavity either by transmission from the
host individual into the vaginal cavity or through curious behaviors of pen-mates
(Fischer-Tenhagen et al., 2012). Likewise, it is possible that CIDRs allow for an influx of
air into the vaginal cavity that may alter bacterial community profiles.
In regards to the physiological measurements collected as part of this study, a
relationship existed between the presence of P. aeruginosa and the amount of PMN,
CBG, and the FCI within the vaginal cavity. More specifically, at the time of CIDR
insertion, heifers with a higher percentage of PMN had a lower abundance of P.
aeruginosa within the cavity. Notoriously, PMN (i.e. neutrophils) are one of the first
defense mechanisms during the initiation of the innate immune response to
inflammation or tissue damage, and function in this manner by killing pathogenic cells or
by destroying host tissue through phagocytosis (Henson and Johnston, 1987; Weiss,
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1989; Kobayashi and DeLeo, 2009). Therefore, we speculate that among heifers with a
greater population of neutrophils within the vagina, the phagocytic properties of the
immune cell may have led to the observed reduction in P. aeruginosa as part of the
host’s innate immune response.
In support of our hypothesis, we observed a negative correlation between the
presence of P. aeruginosa and concentrations of CBG measured within vaginal flush
samples on d 0, such that heifers with a greater abundance of the bacteria had lower
concentrations of CBG. P. aeruginosa produces and releases a protease (LasB) that is
capable of cleaving multiple sites within the amino acid sequence of the RCL (Simard et
al., 2014; Hammond, 2016; Lewis and Elder, 2017). Thus, it is possible that among
heifers with a higher abundance of the bacteria within the vaginal cavity had less CBG
present due to the proteolytic properties of the bacteria. Also during this time, there was
a positive correlation between P. aeruginosa and the free proportion of cortisol (FCI)
within the vaginal flush sample. When proteolytic cleavage of the RCL occurs, the
steroid in which is bound to CBG dissociates and is considered biologically available
which increases the free proportion of the steroid (Siiteri et al., 1981). We also
observed a large increase in the percentage of PMN within the vaginal cavity at the time
of CIDR removal which was directly related to FCI such that heifers with more PMN had
a greater proportion of free cortisol. Therefore, it appears that the amount of free
cortisol may be related to P. aeruginosa and PMN within the cavity, both of which are
capable of causing a reduction in CBG concentration which would result in an increase
in FCI.
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Conclusion
To our knowledge, this is the first study to examine the relationship between
CIDR insertion and the presence of P. aeruginosa inhabiting the vaginal cavity of heifers
using qPCR technologies. Similarly, no other studies have been performed to examine
the relationship between P. aeruginosa abundance and CBG concentration within the
reproductive tract of cattle. As a result of CIDR insertion, we observed a 3.5 fold
reduction in the number of P. aeruginosa inhabiting the vaginal lumen, but we do not
know what induced this response, but we speculate environment and the greater ability
of air to enter the cavity may have altered the bacterial communities. Based on the
results presented in our study, a positive relationship exists between the abundance of
P. aeruginosa and the proportion of free cortisol in the vaginal cavity. Thus, further
investigation is warranted to determine the ability of the P. aeruginosa and PMN to
disrupt steroid binding within the RCL of bovine CBG and if it has the ability to impact
reproductive function in regards to steroid bioavailability in addition to its pathogenic
properties.
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Table 5. Comparison of the abundance (mean CFU·mL-1 ± SEM) of Pseudomonas
aeruginosa in vaginal flush samples collected on d -7 and 0 between heifers that
became pregnant (n = 24) following synchronization of ovulation followed by artificial
insemination and those that remained open (n = 43).
Pregnancy Status on d 38
P-Value
Day1
Open
Pregnant
Day*Preg Status
Day
a
a
-7
10504.23 ± 2455.81 8779.79 ± 2577.22
0.96
<0.0001
0
2980.70b ± 619.24
2550.48b ± 639.47
1
Vaginal flush samples were collected from each heifer immediately prior to CIDR
insertion on d -7 and immediately following CIDR removal on d 0.
ab
Means within a row or column with different superscripts differ.
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Table 6. Mean ± SEM concentrations of endocrine-related variables measured within
the vaginal flush samples collected on d -7 and 0 from heifers undergoing
synchronization of ovulation.
Day
1

Vaginal flush variable
-7
0
P-Value
Progesterone (nmol/L) 33.43b ± 13.64 136.47a ± 27.57 <0.0001
Cortisol (nmol/L) 0.038b ± 0.006 0.076a ± 0.0012 <0.0001
CBG (mg/L)
2.49 ± 0.15
2.66 ± 0.15
0.25
2
b
a
FPI (nmol/mg) 14.58 ± 7.45 52.81 ± 14.20 <0.0001
FCI2 (nmol/mg) 0.016b ± 0.004 0.030a ± 0.006 <0.0001
PMN (%) 7.44b ± 2.70
48.61a ± 2.68 <0.0001
1
Vaginal flush samples were collected from each heifer immediately prior to CIDR
insertion on d -7 and immediately following CIDR removal on d 0.
2
Steroid hormone concentration (nmol/L) was divided by CBG concentration (mg/L) to
calculate a free hormone index (nmol/mg) for both progesterone (FPI) and cortisol
(FCI).
ab
Means with different superscripts differ.
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Table 7. Spearman correlation analysis between Pseudomonas aeruginosa abundance
and endocrine variables measured in vaginal flush samples collected on d -7 and 0 from
heifers undergoing synchronization of ovulation.
Day1
-7
0
-7
0
-7
0
-7
0
-7
0
-7
0

Variable 1
P. aeruginosa abundance
P. aeruginosa abundance
P. aeruginosa abundance
P. aeruginosa abundance
P. aeruginosa abundance
P. aeruginosa abundance
P. aeruginosa abundance
P. aeruginosa abundance
P. aeruginosa abundance
P. aeruginosa abundance
P. aeruginosa abundance
P. aeruginosa abundance

Variable 2
Vaginal [CBG]
Vaginal [CBG]
% PMN
% PMN
Vaginal [Progesterone]
Vaginal [Progesterone]
Vaginal [Cortisol]
Vaginal [Cortisol]
Vaginal FPI2
Vaginal FPI
Vaginal FCI2
Vaginal FCI

1

Correlation
coefficient (r)
-0.002
-0.25
-0.32
0.05
-0.11
-0.19
0.16
0.19
-0.11
-0.06
0.16
0.34

P-Value
0.99
0.05
0.04
0.68
0.48
0.14
0.29
0.14
0.46
0.67
0.31
0.004

Vaginal flush samples were collected from each heifer immediately prior to CIDR
insertion on d -7 and immediately following CIDR removal on d 0.
2
Steroid hormone concentration (nmol/L) was divided by CBG concentration (mg/L) to
calculate a free hormone index (nmol/mg) for both progesterone (FPI) and cortisol
(FCI).
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Chapter IV
Characterization of CBG mRNA expression within bovine vaginal
epithelium and uterine endometrium: a pilot study
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Abstract
Corticosteroid-binding globulin (CBG) is a glycoprotein that serves as a
transporter for glucocorticoids and progesterone. Thus far, CBG has been measured
within the uterus and vaginal lumen in swine and cattle, respectively, but the source of
this glycoprotein remains ill-defined. Therefore, the objective of this pilot study was to
determine if CBG mRNA is expressed locally within the bovine reproductive tract.
Reproductive tracts (n = 3) were collected at the time of evisceration from cattle within
the luteal phase of the estrous cycle. Vaginal epithelial tissue was harvest 2.5 cm
caudal to the cervix, and endometrial tissue from each uterine horn was collected 2.5
cm cranial to the bifurcation and 2.5 cm caudal to the oviduct. Total RNA was extracted
from each tissue sample and cDNA was synthesized via reverse transcription PCR.
CBG gene expression was quantified relative to β-actin via quantitative PCR. A mixed
model analysis of variance was performed to determine if CBG expression levels varied
among the sample collection sites. Within vaginal epithelial tissue samples, the CBG
gene was not expressed. However, expression of the gene was present in the
endometrium, but expression levels did not differ (P = 0.95) among the collection sites.
In summary, it appears that CBG biosynthesis may occur within the uterine
endometrium, but not the vaginal epithelium.
Introduction
Corticosteroid-binding globulin (CBG) is a glycoprotein that is predominantly
synthesized within hepatocytes (Hammond et al., 1991; Heo et al., 2003a) and functions
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as a transporter for glucocorticoids and progesterone in which it binds with high affinity,
but low capacity (Slaunwhite and Sandberg, 1959; Seal et al., 1966; Westphal, 1986a;
Heo et al., 2003b). Corticosteroid-binding globulin is a member of the serine protease
inhibitor superfamily (SERPIN A6) (Hammond et al., 1987; Law et al., 2006). As a
member of this superfamily, CBG acts as a target for proteases (Lin et al., 2010) such
as neutrophil elastase, a protease specifically synthesized and released by neutrophils
(Hammond et al., 1990). More recently chymotrypsin, and LasB, an elastase produced
and released by Pseudomonas aeruginosa have also been reported as proteases
capable of disrupting the RCL (Lewis and Elder, 2014; Simard et al., 2014). In the
presence of CBG, these proteases cleave specific sites within the reactive center loop
(RCL) of CBG and compromise the steroid binding capacity (Lewis and Elder, 2017).
After cleavage, the steroid dissociates from CBG and can be sequestered and loosely
bound by albumin, or remain free within circulation, but in both instances the steroid is
considered biologically available (Simard et al., 2014). Additionally, a consequence of
RCL cleavage includes a 5 kDa reduction in molecular weight and conformational
change that prevents the ability of CBG to bind an additional steroid molecule
(Hammond et al., 1990; Potempa et al., 1994; Silverman et al., 2001).
Glucocorticoids and progesterone compete for the one binding site within the
RCL of CBG, and the concentration of cortisol or progesterone can alter the ratio of
steroids bound within the RCL of CBG (Westphal, 1986a). For example, under periods
of high progesterone production during human pregnancy, progesterone displaces
cortisol from the RCL to occupy the binding site (Rosenthal et al., 1969); whereas,
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during periods of elevated glucocorticoid production, cortisol displaces progesterone
from the RCL (Westphal, 1986a). This interaction signifies the main function of CBG
which includes serving as a buffer and reservoir for glucocorticoids and progesterone
(Rosner, 1991; Sivukhina and Jirikowski, 2014).
In addition to steroid buffering, CBG may also play a role in transporting
progesterone from the corpus luteum (CL) to the uterus (Graham and Clarke, 1997),
but, the exact mechanism of action is not well understood. The presence of CBG
mRNA in steroidogenic tissues, and specifically within both the human corpus luteum
and endometrium supports the theory that CBG plays a role in progesterone transport
and steroidogenic function (Misao et al., 1994; Misao et al., 1997; Misao et al., 1999).
Misao et al. (1997) examined the expression of CBG mRNA in human CL tissue
following hysterectomy procedures and reported a greater expression of CBG mRNA
during the mid-luteal phase of the menstrual cycle when compared to the early and lateluteal phases when concentrations of progesterone are lower than that of the mid-luteal
phase (Misao et al., 1997; Misao et al., 1999). Similarly, CBG mRNA expression within
endometrial tissue is greater during the secretory phase of the menstrual cycle, a phase
characterized by greater progesterone concentrations when compared to the
proliferative phase (Misao et al., 1994). Therefore, it is speculated that CBG may play a
role in the localized transport of progesterone within the reproductive tract of humans,
but to the best of our knowledge the expression of CBG mRNA within the reproductive
tract has not been studied in regards to cattle.
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So far, our lab has shown the ability to quantify CBG within the uterine lumen of
swine (Klemcke et al., 1998), and within the vaginal cavity of cattle as described in
Chapter II of this dissertation. Based on the previous studies described above, CBG
mRNA is expressed locally in the endometrium and luteal tissue in other species, but to
our knowledge synthesis of CBG within the vaginal epithelium has not been explored
and uncertainty remains regarding the source of CBG measured in our experiments.
Thus, the objective of this experiment is to determine if CBG mRNA is expressed locally
in vaginal epithelial and uterine tissue of cattle to allow us to better understand the
source of CBG within the bovine vaginal cavity.
Materials and Methods
Animals
Female reproductive tracts (n = 3) were harvested from cull cattle at a local
abattoir at the time of evisceration which occurred approximately 45 min postexsanguination. Exact breed composition is unknown, but two tracts were from cattle of
dairy breed phenotype and one tract was from that of a cow of beef breed phenotype.
Only non-gravid tracts and those without visible signs of infection were collected. The
stage of the estrous cycle was determined at the time of collection by assessing visible
characteristics of the corpus luteum (CL) as described by Ireland et al. (1980). For this
study, only tracts classified as stage 2 (d 5 to 10 of estrous cycle; red or brown apex
with a yellow body) or 3 (d 11 to 17 of estrous cycle; whole CL is orange or yellow)
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according to the methods of Ireland et al. (1980) were used to determine if bovine CBG
mRNA is expressed within the reproductive tract.
Tissue collection
Using a scalpel, sections of vaginal epithelial and uterine endometrial tissue
samples were cut from the inside of each reproductive tract at locations designated in
Figure 8 of the appendix (Bauersachs et al., 2006; Okumu et al., 2010). Immediately
after collection, tissue sections were placed in a 15 mL conical tube, submerged in
RNAlater (Ambion, Austin, TX), and stored on ice until samples were transported back
to the laboratory (Forde et al., 2009; Okumu et al., 2010). Once back at the laboratory,
tubes containing the tissue sample and RNAlater solution were stored at -80 ⁰C until
later RNA extraction.
RNA extraction
Prior to total RNA extraction, the sections of tissue were frozen in liquid nitrogen,
pulverized using a BioPulverizer (BioSpec Products Inc., Bartlesville, OK), and further
ground to a powder with a mortar and pestle. Ground uterine epithelium (30 mg) and
vaginal endometrium (70 mg) were transferred to culture tubes containing 1 mL Buffer
RTL provided within the Qiagen RNeasy Plus Mini Kit (Qiagen, Hilden, Germany).
Tissues were further homogenized for 30 s using a homogenizer (Laboratory
Homogenizer, Model 125, Thermo Fisher Scientific Co. Pittsburgh, PA) and were then
passed through a 20 gauge needle and syringe to further lyse the tissue. Total RNA
extraction procedures were performed to the specifications of protocol provided within
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the Qiagen RNeasy Plus Mini Kit (Okumu et al., 2010). All samples were eluted in 50
uL of RNase-free water and RNA concentrations were quantified using an Ultrospec
3100 Pro UV/Visible Spectrophotometer (Amersham Bioscience Corp.,
Buckinghamshire, UK). Eluted samples were stored at -80 ⁰ C until cDNA synthesis
was performed.
cDNA synthesis
Total RNA (500 ng) was converted to cDNA through reverse transcription PCR
(RT-PCR) by following the instructions provided within the High Capacity cDNA Reverse
Transcription Kit (Thermo Fisher Scientific, Pittsburgh, PA). Each RT-PCR reaction
contained a total volume of 20 uL which consisted of 10 uL of RT-PCR Master Mix. The
remaining 10 uL consisted of varying volumes of RNA template and RNase-free water
to achieve a final mass of 500 ng of template RNA per RT-PCR reaction tube. Thermal
cycling conditions were performed using a Bio-Rad iCycler (Bio-Rad Laboratories,
Hercules, CA) as per the instructions provided within the High Capacity cDNA Reverse
Transcription Kit (25 ⁰C for 10 min, 37 ⁰C for 120 min, 85 ⁰C for 5 min, and 4 ⁰C for ∞)
and cDNA samples were stored at -20 ⁰C until later quantitative PCR (qPCR) analyses.
Quantitative PCR analysis
Forward (5’-CGCCATGGATGATGATATTGC-3’) and reverse (5’AAGCCGGCCTTGCACAT-3’) primers for β-actin and concentrations (900/300 nM)
used for our experiment were previously validated in bovine endometrial tissue and
were used as a housekeeping gene (Forde et al., 2009; Okumu et al., 2010). Using the
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transcript of SERPINA6 (ENSBTAG00000039808) in Ensembl (www.ensembl.org) and
Primer3Plus (www.bioinformatics.nl/primer3plus), forward (5’-AGCTCAGCCACACTCAT
CCT-3’) and reverse (5’-TTCTCTGGTGCTTTCCAGGT-3’) primers (500 nM) were
designed to span an exon-intron-exon junction within the bovine CBG gene.
Within each qPCR reaction, 500 ng of template cDNA harvested from uterine
endometrial or vaginal epithelial tissue was used (Okumu et al., 2010). For β-actin, a
total reaction volume of 20 uL was used and consisted of 10 uL of PowerUpTM SYBRTM
Green Master Mix (Applied Biosystems, Life Technologies, Carlsbad, CA), 1.8 uL of
forward and 0.6 uL of reverse primers, 6.6 uL RNase-free water, and 1 uL of template
cDNA. Thermal cycling settings included a hold stage of 50 ⁰C for 2 min then 95 ⁰C for
2 min followed by 40 cycles of denaturation at 95⁰ C for 15 sec, annealing at 53⁰ C for 1
min, and extension at 72⁰ C for 1 min. For quantification of CBG gene expression, a
total reaction volume of 20 uL was used and consisted of 10 uL of PowerUp TM SYBRTM
Green Master Mix, 1 uL of forward and 1 uL of reverse primers, 7 uL RNase-free water,
and 1 uL of template cDNA. Thermal cycling settings included a hold stage of 50 ⁰C for
2 min then 95⁰ C for 2 min followed by 40 cycles of denaturation at 95⁰ C for 15 sec,
annealing at 54⁰ C for 1 min, and extension at 72⁰ C for 1 min.
Statistical analysis
Relative expression of the CBG gene was determined by calculating the ΔCt for
each sample relative to the expression of the β-actin gene within the same sample. A
mixed model ANOVA was performed in SAS 9.3 to assess if expression levels varied
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among tissue collection sites. Cow was included as a random blocking term to account
for individual animal variation and Fisher’s LSD test was used to separate means (P ≤
0.05).
Results
All figures are included in the appendix at the end of this chapter. Although βactin was expressed consistently among vaginal epithelial tissue samples (Ct = 20.45 ±
1.50) no amplification of the CBG gene was observed using the qPCR analysis methods
described in the present study. However, we did observe expression among uterine
endometrial tissue samples (Figure 4). Among all four tissue collection sites, CBG
mRNA expression levels were similar (P = 0.95) regardless of proximity to the corpus
luteum, but an overall low expression profile was observed.
Discussion
Based on previous research conducted in our laboratory in which we reported
that CBG concentrations within the uterine lumen rise concurrently with progesterone
concentrations during early gestation in gilts (Klemcke et al., 1998), we chose to
incorporate reproductive tracts harvested from cows within the luteal phase of the
estrous cycle to determine if the CBG gene is expressed locally within the uterine
endometrium and vaginal epithelium. Likewise, in Chapter II we were able to quantify
CBG concentrations within the vaginal lumen of heifers undergoing synchronization of
ovulation. Previous studies conducted by Misao et al. (1994) and Seralini et al. (1990)
reported CBG gene expression within the human endometrium and ovarian, uterine,
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and placental tissues within rabbits. Therefore, within this pilot study, we aimed to
determine if CBG mRNA is expressed within the bovine reproductive tract, and to the
best of our knowledge, this is the first study to investigate CBG gene expression in
regards to cattle.
Due to complications with tissue collection, we were limited to the use of three
reproductive tracts within the luteal phase of the estrous cycle. Nonetheless, we were
able to detect the presence of CBG mRNA expression within the endometrial tissue
samples collected, but not within the vaginal epithelial tissue. Recognizing the
histological difference between the two tissues, it was not surprising that we did not
observed CBG gene expression in the vaginal tissue. The lining of the vagina is
characterized by the presence of stratified squamous epithelial tissue with two
vestibular gland ducts that provide mucus to the vaginal lumen (Bloom and Fawcett,
1975; Blazquez et al., 1987a; Blazquez et al., 1987b). In contrast, the uterine
endometrium consists of a layer of simple columnar epithelial cells that cover the
underlying stroma layer that is comprised by highly glandular tissue that secrete
proteins to the uterine lumen (Dawson, 1959; Bloom and Fawcett, 1975; Gray et al.,
2001). In swine, Murray et al. (1972) observed differences in the concentration of total
protein that was present within uterine flush samples collected at different stages of the
estrous cycle such that protein secretions were greatest under during the luteal phase
and were concurrent with elevated progesterone production (Murray et al., 1972), and
heightened protein synthesis within the endometrial tissue (Basha et al., 1980; Roberts
and Bazer, 1988).
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Among the four sampling locations within the uterus, the bovine CBG mRNA was
present, but expression of the gene was low. This observation was in agreement with
data reported by Seralini et al. (1990) who showed that CBG mRNA is expressed within
the uterus of rabbits, but at much lower of an abundance when compared to hepatic
tissue. Across the sampling sites, CBG mRNA expression was the same. Recognizing
that sample size is a major limitation for this study, a follow-up study with a larger
population size should be conducted to determine if this pattern is consistent or if levels
of CBG mRNA differ among tissue samples collected at varying proximities to the CL.
Within uterine tissue, a progesterone concentration gradient exists such that tissue
samples collected closer to the ovary with the CL contain greater concentrations of
progesterone when compared to tissues collected further away from the CL (Pope et al.,
1982; Weems et al., 1988). Likewise, tissue collected from the contralateral uterine
horn relative to the CL have lower concentrations of progesterone than tissue collected
from the ipsilateral horn (Pope et al., 1982). Based on these observations and the
heightened uterine protein production observed by Murray et al. (1972) during the luteal
phase of the estrous cycle, it is worth investigating to determine if changes in CBG
mRNA expression occur throughout the estrous cycle and if expression levels vary
within samples collected from different regions of the uterus.
Conclusion
To the best of our knowledge, this is the first study to examine bovine CBG gene
expression. The CBG gene was expressed within uterine endometrial tissue, but not in
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vaginal epithelial tissue. Thus, it is possible that CBG measured within the vaginal
cavity of heifers, as described in Chapter II, was originally derived from the
endometrium. Recognizing that the majority of CBG in circulation is produced within the
liver, and CBG possesses a molecular weight of approximately 50-60 kDa, it is not likely
that hepatic-derived CBG alters the concentration within other tissues (Hammond et al.,
1991; Hammond, 2016). To support this claim, immunohistochemical techniques
should be employed to determine if the glycoprotein is produced locally within
endometrial tissue. Nonetheless, it appears that CBG plays a role within the bovine
reproductive tract, but further investigation is warranted to determine its specific function
as it relates to reproductive function.
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Figure 3. Collection sites for vaginal epithelial (red arrow) and uterine endometrial
tissue (blue arrows) harvested from bovine reproductive tracts. Vaginal epithelial
tissue was collected approximately 2.5 cm caudal to the cervix. Uterine endometrial
tissue was collected approximately 2.5 cm cranial to bifurcation and another sample
was collected approximately 2.5 cm caudal to the beginning of the oviduct.
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Figure 4. Relative expression of the bovine CBG gene in endometrial tissue collected
from four sites within the female reproductive tract. Within the uterine horn ipsilateral to
the corpus luteum, endometrial tissue was collected approximately 2.5 cm cranial to
bifurcation (Ipsilateral-1) and another sample was collected approximately 2.5 cm
caudal to the beginning of the oviduct (Ipsilateral-2). Another set of endometrial
samples were collected within the contralateral uterine horn approximately 2.5 cm
cranial to bifurcation (Contralateral-1) and 2.5 cm caudal to the beginning of the oviduct
(Contralateral-2). Expression of the CBG gene is relative to the expression of β-actin.
CBG expression was similar (P = 0.95) among tissue collection sites.
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General Research Conclusions
The studies contained within this dissertation are the first to examine the
influence of progesterone on concentrations of CBG in circulation and within the
reproductive tract of cattle. Likewise, we are the first to explore CBG gene expression
within vaginal epithelial and uterine endometrial tissue in cattle. Previously, research
conducted in regards to humans has shown that CBG biosynthesis and concentrations
of the glycoprotein are altered during heightened progesterone output (Rosenthal et al.,
1969; Benassayag et al., 2001). Recognizing the role of CBG in regulating the
proportion of biologically available steroid, we were interested in examining the effect of
exogenous progesterone administration during synchronization of ovulation and early
gestation in heifers on concentrations of CBG within the vaginal cavity and in circulation.
In Chapter II, no alterations in vaginal or systemic CBG concentrations were
observed during the CIDR insertion period. However, among heifers confirmed as
pregnant on d 38, CBG concentrations in circulation increased during early gestation
when compared to those measured during the synchronization period. Additionally,
based on our FPI calculation that estimates the proportion of bound progesterone to
CBG, it appeared that the overall rise in CBG during early gestation helped to buffer the
amount of free progesterone in circulation during that time period. Across a variety of
species, including humans and cattle, insufficient progesterone concentrations early in
gestation pose a threat to pregnancy sustainability. Based on our preliminary results,
there is evidence to believe that CBG plays a role in progesterone bioavailability. Thus,
future work should be aimed at examining CBG biosynthesis and the amount of free, or
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biologically available progesterone during early gestation to determine if the rate of CBG
production within an animal has the potential to impact the maintenance of pregnancy.
Both P. aeruginosa and neutrophils synthesize and release proteases that cleave
the RCL of CBG to modulate steroid bioavailability by reducing the binding capacity of
the transporter (Hammond et al., 1990; Simard et al., 2014). In Chapter III, CIDR
insertion caused a localized inflammatory response within the vaginal cavity as denoted
by an increase in PMN. Additionally, both PMN and the presence of P. aeruginosa
were directly related to the amount of free cortisol in circulation, but only P. aeruginosa
was related to CBG such that heifers with a higher abundance of the bacteria had lower
concentrations of CBG. Thus far, this study is the first to examine the relationship
between P. aeruginosa and the bioavailability of steroids in cattle, but our preliminary
data suggest that the presence of the bacteria in the vaginal cavity may be capable of
altering the local ratio of free steroid hormone. Although these results were generated
by correlation analysis, future work should be aimed to investigate P. aeruginosa’s role
in disrupting the steroid binding capacity of bovine CBG via in vitro analyses.
Additionally, the potential for P. aeruginosa and PMN to alter the amount of free cortisol
within the vaginal cavity suggests that both are capable of direct impact on the local
inflammatory response.
Lastly, our pilot study described in Chapter IV provided insight as to the source of
CBG measured within the vaginal cavity. Previous research has indicated that although
hepatic production of CBG is the main source for CBG in circulation, is not reflective of
extrahepatic CBG biosynthesis (Hammond, 2016), thus we wanted to examine CBG
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gene expression within the bovine reproductive tract. In our study, CBG mRNA was not
expressed within the vaginal tissue, but was expressed at low levels within the uterine
endometrium. Therefore, we believe CBG measured in the vaginal cavity in Chapter II
was derived from the endometrium. These results are novel in the sense that CBG
gene expression has not been characterized in cattle, but these data reinforce the
notion that CBG is present within tissues under high steroid influence.
In summary, although our studies were limited in regards to the number of cattle
and the number of sampling time points used, our results indicate that CBG acts as a
buffer for steroid hormones during early gestation in beef heifers and is active within the
bovine reproductive tract. We believe the results from these studies set the foundation
for future work in regards to the role of CBG and reproductive function in cattle.
Furthermore, previous research in humans have reported polymorphisms associated
with the SERPINA6 gene that alter the production and steroid binding properties of CBG
(Hammond, 2016). Therefore, further investigation into the variants of the bovine CBG
gene may be warranted to determine if the proportion of free steroid differs among cattle
with varying genotypes.
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Appendix A. Percent recovery assay for evaluating cortisol recovery capability of
Sep-Pak Classic C18 Cartridges (Waters Corporation, Milford, MA)

Procedure (adapted from procedures reported by Shackleton and Whitney (1980))
1. Attach the Sep-Pak Classic C18 Cartridge to a 6 or 12 mL syringe.
2. Prime
a. Add 2 mL of methanol to the barrel of the syringe. Allow the methanol to
flow through the cartridge one drop at a time.
b. Add 5 mL of sterile deionized water to the barrel of the syringe and allow
the water to flow through the cartridge one drop at a time.
3. Sample
a. Add 1 mL of 125I Cortisol Tracer Solution (MP Biomedicals, Solon, OH; cat
# 06B256617) to the barrel and allow contents to flow through the
cartridge one drop at a time.
4. Wash
a. Add 5 mL of sterile deionized water to the barrel of the syringe and allow
water to flow through the cartridge one drop at a time.
5. Recovery/elute
a. Add 2 mL of methanol to the barrel of the syringe, allow methanol to flow
through the cartridge one drop at a time, and collect methanol in a
borosilicate glass test tube.
6. Evaporation and reconstitution
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a. Evaporate recovered methanol under air until borosilicate glass tube is
completely dry.
b. Reconstitute sample with 1 mL of 0.9 % sodium chloride sterile saline.
7. Recovery determination
a. In one polypropylene tube, add 1 mL of straight 125I Cortisol Tracer
Solution. In a separate tube, transfer all contents of the reconstituted
sample in step 6.
b. Run samples through the gamma counter to evaluate counts per minute
(cpm) for each sample.
c. Calculate percent recovery by using the following equation:
% recovery = (recovered sample cpm ÷ straight sample cpm) × 100
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Appendix B. Protocol for concentrating vaginal flush samples for cortisol EIA
using Sep-Pak Classic C18 Cartridges (Waters Corporation, Milford, MA)

Procedure (Shackleton and Whitney, 1980)
1. Attach the Sep-Pak Classic C18 Cartridge to a 6 or 12 mL syringe.
8. Prime
a. Add 2 mL of methanol to the barrel of the syringe. Allow the methanol to
flow through the cartridge one drop at a time.
b. Add 5 mL of sterile deionized water to the barrel of the syringe and allow
the water to flow through the cartridge one drop at a time.
9. Sample
a. Add 5 mL of vaginal flush sample to the barrel of the cartridge and allow
contents to flow through the cartridge one drop at a time.
10. Wash
a. Add 5 mL of sterile deionized water to the barrel of the syringe and allow
water to flow through the cartridge one drop at a time.
11. Recovery/elute
a. Add 2 mL of methanol to the barrel of the syringe, allow methanol to flow
through the cartridge one drop at a time, and collect methanol in a
borosilicate glass test tube.
12. Evaporation and reconstitution
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a. Evaporate recovered methanol under air until borosilicate glass tube is
completely dry.
b. Reconstitute sample with 100 uL of 0.9 % sodium chloride sterile saline.
c. Freeze samples for later analyses.

119

Vita
Sierra A. Lockwood was born in Syracuse, New York in 1990. A little while after,
her family moved back to the family farm in Canandaigua, New York where she was
involved in the Ontario County 4-H program while growing up. In 2008, she graduated
from Canandaigua Academy and moved to Knoxville, Tennessee to attend The
University of Tennessee. She graduated from The University of Tennessee with a
Bachelor of Science in Animal Science with a minor in Biology in May of 2012 and a
Master of Science in Animal Science with a minor in Statistics in December of 2014.
Since then, Sierra has been working toward obtaining her PhD in Animal Science under
the guidance of co-mentors Dr. Henry Kattesh and Dr. Justin Rhinehart at The
University of Tennessee.

120

